{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:58:39Z","timestamp":1788026319698,"version":"build-2784847793"},"reference-count":395,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Innovation Project of Central South University","award":["2025ZZTS0144"],"award-info":[{"award-number":["2025ZZTS0144"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82573989"],"award-info":[{"award-number":["82573989"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09127-1","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:48:50Z","timestamp":1770115730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neuro-immune Crosstalk in Atopic Dermatitis: A Multiaxial Regulatory Network and Novel Therapeutic Perspectives"],"prefix":"10.1007","volume":"69","author":[{"given":"Wanyao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"9127_CR1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.jaci.2025.01.013","volume":"155","author":"S Meledathu","year":"2025","unstructured":"Meledathu S, Naidu MP, Brunner PM (2025) Update on atopic dermatitis. J Allergy Clin Immunol 155:1124\u20131132. https:\/\/doi.org\/10.1016\/j.jaci.2025.01.013","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/s0140-6736(24)02519-4","volume":"405","author":"E Guttman-Yassky","year":"2025","unstructured":"Guttman-Yassky E, Renert-Yuval Y, Brunner PM (2025) Atopic dermatitis. Lancet 405:583\u2013596. https:\/\/doi.org\/10.1016\/s0140-6736(24)02519-4","journal-title":"Lancet"},{"key":"9127_CR3","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1016\/j.jid.2025.03.007","volume":"145","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tang S, Chen X, Wang M, Su J (2025) Association between emotional distress and atopic dermatitis: a cross-sectional study. J Invest Dermatol 145:2613-2615.e2611. https:\/\/doi.org\/10.1016\/j.jid.2025.03.007","journal-title":"J Invest Dermatol"},{"key":"9127_CR4","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jdv.19723","volume":"38","author":"O Faye","year":"2024","unstructured":"Faye O et al (2024) Atopic dermatitis: A global health perspective. J Eur Acad Dermatol Venereol 38:801\u2013811. https:\/\/doi.org\/10.1111\/jdv.19723","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9127_CR5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.anai.2023.08.007","volume":"131","author":"JW Hui-Beckman","year":"2023","unstructured":"Hui-Beckman JW, Goleva E, Leung DYM, Kim BE (2023) The impact of temperature on the skin barrier and atopic dermatitis. Ann Allergy Asthma Immunol 131:713\u2013719. https:\/\/doi.org\/10.1016\/j.anai.2023.08.007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"9127_CR6","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1111\/all.15807","volume":"78","author":"YH Shin","year":"2023","unstructured":"Shin YH et al (2023) Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019. Allergy 78:2232\u20132254. https:\/\/doi.org\/10.1111\/all.15807","journal-title":"Allergy"},{"key":"9127_CR7","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","volume":"143","author":"AS Paller","year":"2019","unstructured":"Paller AS, Spergel JM, Mina-Osorio P, Irvine AD (2019) The atopic march and atopic multimorbidity: many trajectories, many pathways. J Allergy Clin Immunol 143:46\u201355. https:\/\/doi.org\/10.1016\/j.jaci.2018.11.006","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR8","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jaad.2018.08.063","volume":"80","author":"KR Patel","year":"2019","unstructured":"Patel KR, Immaneni S, Singam V, Rastogi S, Silverberg JI (2019) Association between atopic dermatitis, depression, and suicidal ideation: a systematic review and meta-analysis. J Am Acad Dermatol 80:402\u2013410. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.063","journal-title":"J Am Acad Dermatol"},{"key":"9127_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/all.15818","volume":"79","author":"S Cameron","year":"2024","unstructured":"Cameron S et al (2024) Mind and skin: exploring the links between inflammation, sleep disturbance and neurocognitive function in patients with atopic dermatitis. Allergy 79:26\u201336. https:\/\/doi.org\/10.1111\/all.15818","journal-title":"Allergy"},{"key":"9127_CR10","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jdermsci.2021.04.007","volume":"102","author":"T Luger","year":"2021","unstructured":"Luger T et al (2021) Atopic dermatitis: role of the skin barrier, environment, microbiome, and therapeutic agents. J Dermatol Sci 102:142\u2013157. https:\/\/doi.org\/10.1016\/j.jdermsci.2021.04.007","journal-title":"J Dermatol Sci"},{"key":"9127_CR11","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.jid.2023.10.019","volume":"144","author":"CFt Schuler","year":"2024","unstructured":"Schuler CFt et al (2024) Genetic and immunological pathogenesis of Atopic Dermatitis. J Invest Dermatol 144:954\u2013968. https:\/\/doi.org\/10.1016\/j.jid.2023.10.019","journal-title":"J Invest Dermatol"},{"key":"9127_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186484","author":"B Nedoszytko","year":"2020","unstructured":"Nedoszytko B et al (2020) Genetic and epigenetic aspects of atopic dermatitis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21186484","journal-title":"Int J Mol Sci"},{"key":"9127_CR13","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/all.14318","volume":"75","author":"CA Akdis","year":"2020","unstructured":"Akdis CA et al (2020) Type 2 immunity in the skin and lungs. Allergy 75:1582\u20131605. https:\/\/doi.org\/10.1111\/all.14318","journal-title":"Allergy"},{"key":"9127_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/1744666x.2016.1212660","volume":"13","author":"R Kantor","year":"2017","unstructured":"Kantor R, Silverberg JI (2017) Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol 13:15\u201326. https:\/\/doi.org\/10.1080\/1744666x.2016.1212660","journal-title":"Expert Rev Clin Immunol"},{"key":"9127_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113771","volume":"145","author":"C He","year":"2025","unstructured":"He C, Wang Q, Gao J, Chen H, Tong P (2025) Neuro-immune regulation in allergic diseases: role of neuropeptides. Int Immunopharmacol 145:113771. https:\/\/doi.org\/10.1016\/j.intimp.2024.113771","journal-title":"Int Immunopharmacol"},{"key":"9127_CR16","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.alit.2022.04.003","volume":"71","author":"M Tominaga","year":"2022","unstructured":"Tominaga M, Takamori K (2022) Peripheral itch sensitization in atopic dermatitis. Allergol Int 71:265\u2013277. https:\/\/doi.org\/10.1016\/j.alit.2022.04.003","journal-title":"Allergol Int"},{"key":"9127_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2024.102507","volume":"91","author":"L Brabenec","year":"2024","unstructured":"Brabenec L, Gupta S, Eichwald T, Rafei M, Talbot S (2024) Decoding the neuroimmune axis in the atopic march: mechanisms and implications. Curr Opin Immunol 91:102507. https:\/\/doi.org\/10.1016\/j.coi.2024.102507","journal-title":"Curr Opin Immunol"},{"key":"9127_CR18","doi-asserted-by":"publisher","first-page":"1003970","DOI":"10.3389\/fimmu.2022.1003970","volume":"13","author":"E Oleszycka","year":"2022","unstructured":"Oleszycka E et al (2022) Soluble mediators in the function of the epidermal-immune-neuro unit in the skin. Front Immunol 13:1003970. https:\/\/doi.org\/10.3389\/fimmu.2022.1003970","journal-title":"Front Immunol"},{"key":"9127_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084130","author":"J Sroka-Tomaszewska","year":"2021","unstructured":"Sroka-Tomaszewska J, Trzeciak M (2021) Molecular mechanisms of atopic dermatitis pathogenesis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22084130","journal-title":"Int J Mol Sci"},{"key":"9127_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23105318","author":"V Moosbrugger-Martinz","year":"2022","unstructured":"Moosbrugger-Martinz V et al (2022) Revisiting the roles of filaggrin in atopic dermatitis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23105318","journal-title":"Int J Mol Sci"},{"key":"9127_CR21","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/ng1767","volume":"38","author":"CN Palmer","year":"2006","unstructured":"Palmer CN et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441\u2013446. https:\/\/doi.org\/10.1038\/ng1767","journal-title":"Nat Genet"},{"key":"9127_CR22","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jaci.2013.07.027","volume":"133","author":"A Otsuka","year":"2014","unstructured":"Otsuka A et al (2014) Possible new therapeutic strategy to regulate atopic dermatitis through upregulating Filaggrin expression. J Allergy Clin Immunol 133:139\u2013146. https:\/\/doi.org\/10.1016\/j.jaci.2013.07.027. .e131-110","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR23","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s40257-021-00619-2","volume":"22","author":"Y Uchida","year":"2021","unstructured":"Uchida Y, Park K (2021) Ceramides in skin health and disease: an update. Am J Clin Dermatol 22:853\u2013866. https:\/\/doi.org\/10.1007\/s40257-021-00619-2","journal-title":"Am J Clin Dermatol"},{"key":"9127_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1361005","volume":"15","author":"M Afshari","year":"2024","unstructured":"Afshari M, Kolackova M, Rosecka M, \u010celakovsk\u00e1 J, Krejsek J (2024) Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches. Front Immunol 15:1361005. https:\/\/doi.org\/10.3389\/fimmu.2024.1361005","journal-title":"Front Immunol"},{"key":"9127_CR25","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/exd.14806","volume":"32","author":"J Zhang","year":"2023","unstructured":"Zhang J et al (2023) Topical emollient prevents the development of atopic dermatitis and atopic march in mice. Exp Dermatol 32:1007\u20131015. https:\/\/doi.org\/10.1111\/exd.14806","journal-title":"Exp Dermatol"},{"key":"9127_CR26","doi-asserted-by":"publisher","first-page":"329","DOI":"10.2174\/1568010054022033","volume":"4","author":"C Albanesi","year":"2005","unstructured":"Albanesi C, Scarponi C, Giustizieri ML, Girolomoni G (2005) Keratinocytes in inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 4:329\u2013334. https:\/\/doi.org\/10.2174\/1568010054022033","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"9127_CR27","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1172\/jci124608","volume":"129","author":"E Goleva","year":"2019","unstructured":"Goleva E, Berdyshev E, Leung DY (2019) Epithelial barrier repair and prevention of allergy. J Clin Invest 129:1463\u20131474. https:\/\/doi.org\/10.1172\/jci124608","journal-title":"J Clin Invest"},{"key":"9127_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jid.2024.03.006","volume":"144","author":"M Schmuth","year":"2024","unstructured":"Schmuth M et al (2024) Skin barrier in atopic dermatitis. J Invest Dermatol 144:989\u20131000e1001. https:\/\/doi.org\/10.1016\/j.jid.2024.03.006","journal-title":"J Invest Dermatol"},{"key":"9127_CR29","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.yadr.2008.09.004","volume":"24","author":"LS Miller","year":"2008","unstructured":"Miller LS (2008) Toll-like receptors in skin. Adv Dermatol 24:71\u201387. https:\/\/doi.org\/10.1016\/j.yadr.2008.09.004","journal-title":"Adv Dermatol"},{"key":"9127_CR30","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1111\/j.1600-0625.2010.01140.x","volume":"19","author":"M Niebuhr","year":"2010","unstructured":"Niebuhr M, Baumert K, Werfel T (2010) TLR-2-mediated cytokine and chemokine secretion in human keratinocytes. Exp Dermatol 19:873\u2013877. https:\/\/doi.org\/10.1111\/j.1600-0625.2010.01140.x","journal-title":"Exp Dermatol"},{"key":"9127_CR31","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.intimp.2007.02.003","volume":"7","author":"JY Liu","year":"2007","unstructured":"Liu JY et al (2007) Effect of matrine on the expression of substance P receptor and inflammatory cytokines production in human skin keratinocytes and fibroblasts. Int Immunopharmacol 7:816\u2013823. https:\/\/doi.org\/10.1016\/j.intimp.2007.02.003","journal-title":"Int Immunopharmacol"},{"key":"9127_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.627985","volume":"8","author":"A Ruppenstein","year":"2021","unstructured":"Ruppenstein A et al (2021) Involvement of neuro-immune interactions in pruritus with special focus on receptor expressions. Front Med (Lausanne) 8:627985. https:\/\/doi.org\/10.3389\/fmed.2021.627985","journal-title":"Front Med (Lausanne)"},{"key":"9127_CR33","doi-asserted-by":"publisher","first-page":"6176","DOI":"10.1523\/jneurosci.23-15-06176.2003","volume":"23","author":"M Steinhoff","year":"2003","unstructured":"Steinhoff M et al (2003) Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 23:6176\u20136180. https:\/\/doi.org\/10.1523\/jneurosci.23-15-06176.2003","journal-title":"J Neurosci"},{"key":"9127_CR34","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.jid.2018.01.034","volume":"138","author":"O Gouin","year":"2018","unstructured":"Gouin O et al (2018) Major role for TRPV1 and InsP3R in PAR2-Elicited inflammatory mediator production in differentiated human keratinocytes. J Invest Dermatol 138:1564\u20131572. https:\/\/doi.org\/10.1016\/j.jid.2018.01.034","journal-title":"J Invest Dermatol"},{"key":"9127_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.coi.2012.11.007","volume":"25","author":"BZ Igy\u00e1rt\u00f3","year":"2013","unstructured":"Igy\u00e1rt\u00f3 BZ, Kaplan DH (2013) Antigen presentation by Langerhans cells. Curr Opin Immunol 25:115\u2013119. https:\/\/doi.org\/10.1016\/j.coi.2012.11.007","journal-title":"Curr Opin Immunol"},{"key":"9127_CR36","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1016\/j.immuni.2021.08.012","volume":"54","author":"X Liu","year":"2021","unstructured":"Liu X et al (2021) Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation. Immunity 54:2305\u20132320e2311. https:\/\/doi.org\/10.1016\/j.immuni.2021.08.012","journal-title":"Immunity"},{"key":"9127_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/srt.13858","volume":"30","author":"X Zhu","year":"2024","unstructured":"Zhu X, Wu W (2024) The causal relationship between immune cells and atopic dermatitis: a bidirectional Mendelian randomization study. Skin Res Technol 30:e13858. https:\/\/doi.org\/10.1111\/srt.13858","journal-title":"Skin Res Technol"},{"key":"9127_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.630892","volume":"12","author":"K Rindler","year":"2021","unstructured":"Rindler K et al (2021) Spontaneously resolved atopic dermatitis shows melanocyte and immune cell activation distinct from healthy control skin. Front Immunol 12:630892. https:\/\/doi.org\/10.3389\/fimmu.2021.630892","journal-title":"Front Immunol"},{"key":"9127_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba6500","author":"G Reynolds","year":"2021","unstructured":"Reynolds G et al (2021) Developmental cell programs are co-opted in inflammatory skin disease. Science. https:\/\/doi.org\/10.1126\/science.aba6500","journal-title":"Science"},{"key":"9127_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1172\/jci93555","volume":"128","author":"MD Lynch","year":"2018","unstructured":"Lynch MD, Watt FM (2018) Fibroblast heterogeneity: implications for human disease. J Clin Invest 128:26\u201335. https:\/\/doi.org\/10.1172\/jci93555","journal-title":"J Clin Invest"},{"key":"9127_CR41","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41586-021-04221-8","volume":"601","author":"Z Xu","year":"2022","unstructured":"Xu Z et al (2022) Anatomically distinct fibroblast subsets determine skin autoimmune patterns. Nature 601:118\u2013124. https:\/\/doi.org\/10.1038\/s41586-021-04221-8","journal-title":"Nature"},{"key":"9127_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jdermsci.2024.04.002","volume":"114","author":"Y Luo","year":"2024","unstructured":"Luo Y et al (2024) Senescent fibroblasts and innate immune cell activation might play a role in the pathogenesis of elderly atopic dermatitis. J Dermatol Sci 114:94\u2013103. https:\/\/doi.org\/10.1016\/j.jdermsci.2024.04.002","journal-title":"J Dermatol Sci"},{"key":"9127_CR43","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.jaci.2020.01.042","volume":"145","author":"H He","year":"2020","unstructured":"He H et al (2020) Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis. J Allergy Clin Immunol 145:1615\u20131628. https:\/\/doi.org\/10.1016\/j.jaci.2020.01.042","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37798-x","volume":"14","author":"X Cai","year":"2023","unstructured":"Cai X et al (2023) Tenascin C(+) papillary fibroblasts facilitate neuro-immune interaction in a mouse model of psoriasis. Nat Commun 14:2004. https:\/\/doi.org\/10.1038\/s41467-023-37798-x","journal-title":"Nat Commun"},{"key":"9127_CR45","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.devcel.2020.11.002","volume":"56","author":"Z Zou","year":"2021","unstructured":"Zou Z et al (2021) A Single-Cell transcriptomic atlas of human skin aging. Dev Cell 56:383\u2013397e388. https:\/\/doi.org\/10.1016\/j.devcel.2020.11.002","journal-title":"Dev Cell"},{"key":"9127_CR46","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","volume":"21","author":"K Wolk","year":"2004","unstructured":"Wolk K et al (2004) IL-22 increases the innate immunity of tissues. Immunity 21:241\u2013254. https:\/\/doi.org\/10.1016\/j.immuni.2004.07.007","journal-title":"Immunity"},{"key":"9127_CR47","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.jaci.2012.07.012","volume":"130","author":"JK Gittler","year":"2012","unstructured":"Gittler JK et al (2012) Progressive activation of T(H)2\/T(H)22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis. J Allergy Clin Immunol 130:1344\u20131354. https:\/\/doi.org\/10.1016\/j.jaci.2012.07.012","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR48","doi-asserted-by":"publisher","unstructured":"Murota H et al (2012) Artemin causes hypersensitivity to warm sensation, mimicking warmth-provoked pruritus in atopic dermatitis. J Allergy Clin Immunol 130, 671\u2013682.e674 https:\/\/doi.org\/10.1016\/j.jaci.2012.05.027","DOI":"10.1016\/j.jaci.2012.05.027"},{"key":"9127_CR49","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14970","volume":"33","author":"YN Jang","year":"2024","unstructured":"Jang YN et al (2024) Exosomes derived from human dermal fibroblasts (HDFn-Ex) alleviate DNCB-induced atopic dermatitis (AD) via PPAR\u03b1. Exp Dermatol 33:e14970. https:\/\/doi.org\/10.1111\/exd.14970","journal-title":"Exp Dermatol"},{"key":"9127_CR50","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3389\/fimmu.2020.00752","volume":"11","author":"T Hou","year":"2020","unstructured":"Hou T et al (2020) IL-37 ameliorating allergic inflammation in atopic dermatitis through regulating microbiota and AMPK-mTOR signaling Pathway-Modulated autophagy mechanism. Front Immunol 11:752. https:\/\/doi.org\/10.3389\/fimmu.2020.00752","journal-title":"Front Immunol"},{"key":"9127_CR51","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000534568","volume":"185","author":"L Zhou","year":"2024","unstructured":"Zhou L et al (2024) Blockade of HMGB1 reduces inflammation and pruritus in atopic dermatitis by inhibiting skin fibroblasts activation. Int Arch Allergy Immunol 185:170\u2013181. https:\/\/doi.org\/10.1159\/000534568","journal-title":"Int Arch Allergy Immunol"},{"key":"9127_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24055001","author":"L Marek-Jozefowicz","year":"2023","unstructured":"Marek-Jozefowicz L et al (2023) Molecular mechanisms of neurogenic inflammation of the skin. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24055001","journal-title":"Int J Mol Sci"},{"key":"9127_CR53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1398-9995.2004.00628.x","volume":"60","author":"DA Groneberg","year":"2005","unstructured":"Groneberg DA et al (2005) Mast cells and vasculature in atopic dermatitis\u2013potential stimulus of neoangiogenesis. Allergy 60:90\u201397. https:\/\/doi.org\/10.1111\/j.1398-9995.2004.00628.x","journal-title":"Allergy"},{"key":"9127_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222112035","author":"HJ Lee","year":"2021","unstructured":"Lee HJ, Hong YJ, Kim M (2021) Angiogenesis in chronic inflammatory skin disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222112035","journal-title":"Int J Mol Sci"},{"key":"9127_CR55","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.alit.2016.12.002","volume":"66","author":"M Furue","year":"2017","unstructured":"Furue M et al (2017) Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergol Int 66:398\u2013403. https:\/\/doi.org\/10.1016\/j.alit.2016.12.002","journal-title":"Allergol Int"},{"key":"9127_CR56","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1111\/ijd.13132","volume":"55","author":"Z Samochocki","year":"2016","unstructured":"Samochocki Z et al (2016) Expression of vascular endothelial growth factor and other cytokines in atopic dermatitis, and correlation with clinical features. Int J Dermatol 55:e141-146. https:\/\/doi.org\/10.1111\/ijd.13132","journal-title":"Int J Dermatol"},{"key":"9127_CR57","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000331883","volume":"96","author":"A Genovese","year":"2012","unstructured":"Genovese A et al (2012) Angiogenesis, lymphangiogenesis and atopic dermatitis. Chem Immunol Allergy 96:50\u201360. https:\/\/doi.org\/10.1159\/000331883","journal-title":"Chem Immunol Allergy"},{"key":"9127_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00403-006-0641-9","volume":"297","author":"Y Zhang","year":"2006","unstructured":"Zhang Y, Matsuo H, Morita E (2006) Increased production of vascular endothelial growth factor in the lesions of atopic dermatitis. Arch Dermatol Res 297:425\u2013429. https:\/\/doi.org\/10.1007\/s00403-006-0641-9","journal-title":"Arch Dermatol Res"},{"key":"9127_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1468-3083.2009.03307.x","volume":"24","author":"M Zablotna","year":"2010","unstructured":"Zablotna M et al (2010) Association between the \u2212\u20091154 G\/A promoter polymorphism of the vascular endothelial growth factor gene and atopic dermatitis. J Eur Acad Dermatol Venereol 24:91\u201392. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03307.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9127_CR60","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1038\/jid.2008.111","volume":"128","author":"C Koga","year":"2008","unstructured":"Koga C, Kabashima K, Shiraishi N, Kobayashi M, Tokura Y (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128:2625\u20132630. https:\/\/doi.org\/10.1038\/jid.2008.111","journal-title":"J Invest Dermatol"},{"key":"9127_CR61","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.cmet.2010.05.015","volume":"12","author":"D Yang","year":"2010","unstructured":"Yang D et al (2010) Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. Cell Metab 12:130\u2013141. https:\/\/doi.org\/10.1016\/j.cmet.2010.05.015","journal-title":"Cell Metab"},{"key":"9127_CR62","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/cvr\/cvr104","volume":"91","author":"LC Ching","year":"2011","unstructured":"Ching LC et al (2011) Molecular mechanisms of activation of endothelial nitric oxide synthase mediated by transient receptor potential vanilloid type 1. Cardiovasc Res 91:492\u2013501. https:\/\/doi.org\/10.1093\/cvr\/cvr104","journal-title":"Cardiovasc Res"},{"key":"9127_CR63","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bbi.2011.02.007","volume":"25","author":"J Huang","year":"2011","unstructured":"Huang J, Stohl LL, Zhou X, Ding W, Granstein RD (2011) Calcitonin gene-related peptide inhibits chemokine production by human dermal microvascular endothelial cells. Brain Behav Immun 25:787\u2013799. https:\/\/doi.org\/10.1016\/j.bbi.2011.02.007","journal-title":"Brain Behav Immun"},{"key":"9127_CR64","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1161\/circresaha.108.189530","volume":"104","author":"S Earley","year":"2009","unstructured":"Earley S, Gonzales AL, Crnich R (2009) Endothelium-dependent cerebral artery dilation mediated by TRPA1 and Ca2+-activated K\u2009+\u2009channels. Circ Res 104:987\u2013994. https:\/\/doi.org\/10.1161\/circresaha.108.189530","journal-title":"Circ Res"},{"key":"9127_CR65","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.taap.2008.01.021","volume":"229","author":"BC Liao","year":"2008","unstructured":"Liao BC et al (2008) Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2. Toxicol Appl Pharmacol 229:161\u2013171. https:\/\/doi.org\/10.1016\/j.taap.2008.01.021","journal-title":"Toxicol Appl Pharmacol"},{"key":"9127_CR66","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.jid.2019.07.700","volume":"140","author":"CCL van Aanhold","year":"2020","unstructured":"van Aanhold CCL et al (2020) The vascular endothelial growth factor inhibitor soluble FLT-1 ameliorates atopic dermatitis in APOC1 Transgenic mice. J Invest Dermatol 140:491\u2013494e494. https:\/\/doi.org\/10.1016\/j.jid.2019.07.700","journal-title":"J Invest Dermatol"},{"key":"9127_CR67","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jaci.2024.02.005","volume":"153","author":"C Bao","year":"2024","unstructured":"Bao C, Abraham SN (2024) Mast cell-sensory neuron crosstalk in allergic diseases. J Allergy Clin Immunol 153:939\u2013953. https:\/\/doi.org\/10.1016\/j.jaci.2024.02.005","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR68","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250359","volume":"53","author":"YH Keith","year":"2023","unstructured":"Keith YH, Egawa G, Honda T, Kabashima K (2023) Mast cells in type 2 skin inflammation: maintenance and function. Eur J Immunol 53:e2250359. https:\/\/doi.org\/10.1002\/eji.202250359","journal-title":"Eur J Immunol"},{"key":"9127_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24087021","author":"E Wo\u017aniak","year":"2023","unstructured":"Wo\u017aniak E et al (2023) The role of mast cells in the induction and maintenance of inflammation in selected skin diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24087021","journal-title":"Int J Mol Sci"},{"key":"9127_CR70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.it.2017.10.005","volume":"39","author":"F Siebenhaar","year":"2018","unstructured":"Siebenhaar F, Redegeld FA, Bischoff SC, Gibbs BF, Maurer M (2018) Mast cells as drivers of disease and therapeutic targets. Trends Immunol 39:151\u2013162. https:\/\/doi.org\/10.1016\/j.it.2017.10.005","journal-title":"Trends Immunol"},{"key":"9127_CR71","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.4049\/jimmunol.2001278","volume":"207","author":"RP Mendoza","year":"2021","unstructured":"Mendoza RP, Anderson CC, Fudge DH, Roede JR, Brown JM (2021) Metabolic consequences of IgE- and non-IgE-mediated mast cell degranulation. J Immunol 207:2637\u20132648. https:\/\/doi.org\/10.4049\/jimmunol.2001278","journal-title":"J Immunol"},{"key":"9127_CR72","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1124\/pr.113.008425","volume":"66","author":"HJ Solinski","year":"2014","unstructured":"Solinski HJ, Gudermann T, Breit A (2014) Pharmacology and signaling of MAS-related G protein-coupled receptors. Pharmacol Rev 66:570\u2013597. https:\/\/doi.org\/10.1124\/pr.113.008425","journal-title":"Pharmacol Rev"},{"key":"9127_CR73","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaci.2022.09.011","volume":"151","author":"YH Keith","year":"2023","unstructured":"Keith YH et al (2023) Infiltration and local differentiation of bone marrow-derived integrin\u03b27-positive mast cell progenitors in atopic dermatitis-like skin. J Allergy Clin Immunol 151:159\u2013171e158. https:\/\/doi.org\/10.1016\/j.jaci.2022.09.011","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR74","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/exd.14425","volume":"30","author":"Y Mizutani","year":"2021","unstructured":"Mizutani Y, Takagi N, Nagata H, Inoue S (2021) Interferon-\u03b3 downregulates tight junction function, which is rescued by interleukin-17A. Exp Dermatol 30:1754\u20131763. https:\/\/doi.org\/10.1111\/exd.14425","journal-title":"Exp Dermatol"},{"key":"9127_CR75","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.152559","author":"X Luo","year":"2022","unstructured":"Luo X et al (2022) Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.152559","journal-title":"JCI Insight"},{"key":"9127_CR76","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/itt.S260370","volume":"9","author":"A Chiricozzi","year":"2020","unstructured":"Chiricozzi A, Maurelli M, Peris K, Girolomoni G (2020) Targeting IL-4 for the treatment of atopic dermatitis. Immunotargets Ther 9:151\u2013156. https:\/\/doi.org\/10.2147\/itt.S260370","journal-title":"Immunotargets Ther"},{"key":"9127_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00120","volume":"3","author":"G Gri","year":"2012","unstructured":"Gri G et al (2012) Mast cell: an emerging partner in immune interaction. Front Immunol 3:120. https:\/\/doi.org\/10.3389\/fimmu.2012.00120","journal-title":"Front Immunol"},{"key":"9127_CR78","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/bjd.12108","volume":"168","author":"M Hagiyama","year":"2013","unstructured":"Hagiyama M et al (2013) Increased expression of cell adhesion molecule 1 by mast cells as a cause of enhanced nerve-mast cell interaction in a hapten-induced mouse model of atopic dermatitis. Br J Dermatol 168:771\u2013778. https:\/\/doi.org\/10.1111\/bjd.12108","journal-title":"Br J Dermatol"},{"key":"9127_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2019.00262","volume":"13","author":"R Magadmi","year":"2019","unstructured":"Magadmi R, Meszaros J, Damanhouri ZA, Seward EP (2019) Secretion of mast cell inflammatory mediators is enhanced by CADM1-dependent adhesion to sensory neurons. Front Cell Neurosci 13:262. https:\/\/doi.org\/10.3389\/fncel.2019.00262","journal-title":"Front Cell Neurosci"},{"key":"9127_CR80","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1084\/jem.20130351","volume":"210","author":"M Salimi","year":"2013","unstructured":"Salimi M et al (2013) A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210:2939\u20132950. https:\/\/doi.org\/10.1084\/jem.20130351","journal-title":"J Exp Med"},{"key":"9127_CR81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/intimm\/dxv044","volume":"28","author":"Y Huang","year":"2016","unstructured":"Huang Y, Paul WE (2016) Inflammatory group 2 innate lymphoid cells. Int Immunol 28:23\u201328. https:\/\/doi.org\/10.1093\/intimm\/dxv044","journal-title":"Int Immunol"},{"key":"9127_CR82","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.alit.2023.01.002","volume":"72","author":"Y Imai","year":"2023","unstructured":"Imai Y (2023) ILC2s in skin disorders. Allergol Int 72:201\u2013206. https:\/\/doi.org\/10.1016\/j.alit.2023.01.002","journal-title":"Allergol Int"},{"key":"9127_CR83","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cyto.2015.05.010","volume":"75","author":"J Zhu","year":"2015","unstructured":"Zhu J (2015) T helper 2 (Th2) cell differentiation, type 2 innate lymphoid cell (ILC2) development and regulation of interleukin-4 (IL-4) and IL-13 production. Cytokine 75:14\u201324. https:\/\/doi.org\/10.1016\/j.cyto.2015.05.010","journal-title":"Cytokine"},{"key":"9127_CR84","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/00054725-199911000-00009","volume":"5","author":"S Romagnani","year":"1999","unstructured":"Romagnani S (1999) <article-title update=\"added\">Th1\/Th2 Cells: Inflamm Bowel Dis 5:285\u2013294. https:\/\/doi.org\/10.1097\/00054725-199911000-00009","journal-title":"Inflamm Bowel Dis"},{"key":"9127_CR85","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/1744666x.2021.1940962","volume":"17","author":"C Dubin","year":"2021","unstructured":"Dubin C, Del Duca E, Guttman-Yassky E (2021) The IL-4, IL-13 and IL-31 pathways in atopic dermatitis. Expert Rev Clin Immunol 17:835\u2013852. https:\/\/doi.org\/10.1080\/1744666x.2021.1940962","journal-title":"Expert Rev Clin Immunol"},{"key":"9127_CR86","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s12016-021-08880-3","volume":"61","author":"H Li","year":"2021","unstructured":"Li H, Zhang Z, Zhang H, Guo Y, Yao Z (2021) Update on the pathogenesis and therapy of atopic dermatitis. Clin Rev Allergy Immunol 61:324\u2013338. https:\/\/doi.org\/10.1007\/s12016-021-08880-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"9127_CR87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-319-64804-0_3","volume":"1027","author":"D Boothe","year":"2017","unstructured":"Boothe D, Tarbox W, J. A., Tarbox MB (2017) Atopic dermatitis: pathophysiology. Adv Exp Med Biol 1027:21\u201337. https:\/\/doi.org\/10.1007\/978-3-319-64804-0_3","journal-title":"Adv Exp Med Biol"},{"key":"9127_CR88","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s13555-022-00737-7","volume":"12","author":"EB Haddad","year":"2022","unstructured":"Haddad EB (2022) <article-title update=\"added\">Current and Emerging Strategies to Inhibit Type\u00a02 Inflammation in Atopic Dermatitis. Dermatol Ther 12:1501\u20131533. https:\/\/doi.org\/10.1007\/s13555-022-00737-7","journal-title":"Dermatol Ther"},{"key":"9127_CR89","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi6887","volume":"8","author":"MS Fassett","year":"2023","unstructured":"Fassett MS (2023) <article-title update=\"added\">IL-31\u2013dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis. Sci Immunol 8:eabi6887. https:\/\/doi.org\/10.1126\/sciimmunol.abi6887","journal-title":"Sci Immunol"},{"key":"9127_CR90","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.4049\/jimmunol.1402943","volume":"196","author":"KH H\u00e4nel","year":"2016","unstructured":"H\u00e4nel KH et al (2016) Control of the physical and antimicrobial skin barrier by an IL-31-IL-1 signaling network. J Immunol 196:3233\u20133244. https:\/\/doi.org\/10.4049\/jimmunol.1402943","journal-title":"J Immunol"},{"key":"9127_CR91","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","volume":"41","author":"FT Liu","year":"2011","unstructured":"Liu FT, Goodarzi H, Chen HY (2011) IgE, mast cells, and eosinophils in atopic dermatitis. Clin Rev Allergy Immunol 41:298\u2013310. https:\/\/doi.org\/10.1007\/s12016-011-8252-4","journal-title":"Clin Rev Allergy Immunol"},{"key":"9127_CR92","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/all.12916","volume":"71","author":"R F\u00f6lster-Holst","year":"2016","unstructured":"F\u00f6lster-Holst R et al (2016) Childhood atopic dermatitis-brain-derived neurotrophic factor correlates with serum eosinophil cationic protein and disease severity. Allergy 71:1062\u20131065. https:\/\/doi.org\/10.1111\/all.12916","journal-title":"Allergy"},{"key":"9127_CR93","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/cea.13560","volume":"50","author":"D Guseva","year":"2020","unstructured":"Guseva D et al (2020) Neuronal branching of sensory neurons is associated with BDNF-positive eosinophils in atopic dermatitis. Clin Exp Allergy 50:577\u2013584. https:\/\/doi.org\/10.1111\/cea.13560","journal-title":"Clin Exp Allergy"},{"key":"9127_CR94","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1111\/j.1365-2222.2008.03035.x","volume":"38","author":"U Raap","year":"2008","unstructured":"Raap U, Deneka N, Bruder M, Kapp A, Wedi B (2008) Differential up-regulation of neurotrophin receptors and functional activity of neurotrophins on peripheral blood eosinophils of patients with allergic rhinitis, atopic dermatitis and nonatopic subjects. Clin Exp Allergy 38:1493\u20131498. https:\/\/doi.org\/10.1111\/j.1365-2222.2008.03035.x","journal-title":"Clin Exp Allergy"},{"key":"9127_CR95","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1182\/blood.V88.7.2458.bloodjournal8872458","volume":"88","author":"R Nishinakamura","year":"1996","unstructured":"Nishinakamura R, Miyajima A, Mee PJ, Tybulewicz VL, Murray R (1996) Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor\/interleukin-3\/interleukin-5 functions. Blood 88:2458\u20132464","journal-title":"Blood"},{"key":"9127_CR96","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/00015550310016472","volume":"83","author":"K Masuda","year":"2003","unstructured":"Masuda K, Katoh N, Okuda F, Kishimoto S (2003) Increased levels of serum interleukin-16 in adult type atopic dermatitis. Acta Derm Venereol 83:249\u2013253. https:\/\/doi.org\/10.1080\/00015550310016472","journal-title":"Acta Derm Venereol"},{"key":"9127_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031922","author":"T Weihrauch","year":"2024","unstructured":"Weihrauch T et al (2024) TRPV1 channel in human eosinophils: functional expression and inflammatory modulation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25031922","journal-title":"Int J Mol Sci"},{"key":"9127_CR98","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.immuni.2020.10.001","volume":"53","author":"C Perner","year":"2020","unstructured":"Perner C et al (2020) Substance P release by sensory neurons triggers dendritic cell migration and initiates the Type-2 immune response to allergens. Immunity 53:1063\u20131077e1067. https:\/\/doi.org\/10.1016\/j.immuni.2020.10.001","journal-title":"Immunity"},{"key":"9127_CR99","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jaci.2021.02.005","volume":"148","author":"Y Yamamoto","year":"2021","unstructured":"Yamamoto Y et al (2021) Pituitary adenylate cyclase-activating polypeptide promotes cutaneous dendritic cell functions in contact hypersensitivity. J Allergy Clin Immunol 148:858\u2013866. https:\/\/doi.org\/10.1016\/j.jaci.2021.02.005","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR100","doi-asserted-by":"publisher","first-page":"1593141","DOI":"10.3389\/fimmu.2025.1593141","volume":"16","author":"D Horv\u00e1th","year":"2025","unstructured":"Horv\u00e1th D et al (2025) Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype. Front Immunol 16:1593141. https:\/\/doi.org\/10.3389\/fimmu.2025.1593141","journal-title":"Front Immunol"},{"key":"9127_CR101","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/ncomms3847","volume":"4","author":"JM Leyva-Castillo","year":"2013","unstructured":"Leyva-Castillo JM et al (2013) Skin thymic stromal lymphopoietin initiates Th2 responses through an orchestrated immune cascade. Nat Commun 4:2847. https:\/\/doi.org\/10.1038\/ncomms3847","journal-title":"Nat Commun"},{"key":"9127_CR102","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022087118","author":"T Voisin","year":"2021","unstructured":"Voisin T et al (2021) The CysLT(2)R receptor mediates leukotriene C(4)-driven acute and chronic itch. Proc Natl Acad Sci U S A. https:\/\/doi.org\/10.1073\/pnas.2022087118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9127_CR103","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.cell.2020.12.033","volume":"184","author":"F Wang","year":"2021","unstructured":"Wang F et al (2021) A basophil-neuronal axis promotes itch. Cell 184:422\u2013440e417. https:\/\/doi.org\/10.1016\/j.cell.2020.12.033","journal-title":"Cell"},{"key":"9127_CR104","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/nature12479","volume":"501","author":"IM Chiu","year":"2013","unstructured":"Chiu IM et al (2013) Bacteria activate sensory neurons that modulate pain and inflammation. Nature 501:52\u201357. https:\/\/doi.org\/10.1038\/nature12479","journal-title":"Nature"},{"key":"9127_CR105","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.immuni.2015.08.016","volume":"43","author":"SW Kashem","year":"2015","unstructured":"Kashem SW et al (2015) Nociceptive sensory fibers drive Interleukin-23 production from CD301b\u2009+\u2009Dermal dendritic cells and drive protective cutaneous immunity. Immunity 43:515\u2013526. https:\/\/doi.org\/10.1016\/j.immuni.2015.08.016","journal-title":"Immunity"},{"key":"9127_CR106","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.immuni.2020.04.008","volume":"52","author":"F Wang","year":"2020","unstructured":"Wang F, Kim BS (2020) Itch: a paradigm of neuroimmune crosstalk. Immunity 52:753\u2013766. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.008","journal-title":"Immunity"},{"key":"9127_CR107","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.it.2016.10.001","volume":"38","author":"FA Pinho-Ribeiro","year":"2017","unstructured":"Pinho-Ribeiro FA, Verri WA Jr., Chiu IM (2017) Nociceptor Sensory Neuron-Immune Interactions in Pain and Inflammation. Trends Immunol 38:5\u201319. https:\/\/doi.org\/10.1016\/j.it.2016.10.001","journal-title":"Trends Immunol"},{"key":"9127_CR108","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s13238-017-0395-5","volume":"8","author":"O Gouin","year":"2017","unstructured":"Gouin O et al (2017) TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization. Protein Cell 8:644\u2013661. https:\/\/doi.org\/10.1007\/s13238-017-0395-5","journal-title":"Protein Cell"},{"key":"9127_CR109","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/cne.20794","volume":"493","author":"K Kobayashi","year":"2005","unstructured":"Kobayashi K et al (2005) Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with a\u03b4\/c\u2010fibers and colocalization with trk receptors. J Comp Neurol 493:596\u2013606. https:\/\/doi.org\/10.1002\/cne.20794","journal-title":"J Comp Neurol"},{"key":"9127_CR110","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jaci.2022.01.027","volume":"150","author":"BE Kim","year":"2022","unstructured":"Kim BE et al (2022) Transient receptor potential vanilloid 1 plays a major role in low temperature-mediated skin barrier dysfunction. J Allergy Clin Immunol 150:362\u2013372e367. https:\/\/doi.org\/10.1016\/j.jaci.2022.01.027","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR111","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1111\/exd.14464","volume":"31","author":"L Tang","year":"2022","unstructured":"Tang L et al (2022) TRPV1 mediates itch-associated scratching and skin barrier dysfunction in DNFB-induced atopic dermatitis mice. Exp Dermatol 31:398\u2013405. https:\/\/doi.org\/10.1111\/exd.14464","journal-title":"Exp Dermatol"},{"key":"9127_CR112","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/sj.jid.5700590","volume":"127","author":"M Denda","year":"2007","unstructured":"Denda M, Sokabe T, Fukumi-Tominaga T, Tominaga M (2007) Effects of skin surface temperature on epidermal permeability barrier homeostasis. J Invest Dermatol 127:654\u2013659. https:\/\/doi.org\/10.1038\/sj.jid.5700590","journal-title":"J Invest Dermatol"},{"key":"9127_CR113","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jdermsci.2010.10.014","volume":"62","author":"JW Yun","year":"2011","unstructured":"Yun JW et al (2011) TRPV1 antagonist can suppress the atopic dermatitis-like symptoms by accelerating skin barrier recovery. J Dermatol Sci 62:8\u201315. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.10.014","journal-title":"J Dermatol Sci"},{"key":"9127_CR114","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jaci.2021.09.024","volume":"149","author":"CW Park","year":"2022","unstructured":"Park CW et al (2022) Asivatrep, a TRPV1 antagonist, for the topical treatment of atopic dermatitis: phase 3, randomized, vehicle-controlled study (CAPTAIN-AD). J Allergy Clin Immunol 149:1340\u20131347e1344. https:\/\/doi.org\/10.1016\/j.jaci.2021.09.024","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR115","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1111\/jdv.19694","volume":"38","author":"S Moon","year":"2024","unstructured":"Moon S et al (2024) Clinically uninvolved but not healthy-The skin of patients with atopic dermatitis is primed for itch and inflammation. J Eur Acad Dermatol Venereol 38:1089\u20131100. https:\/\/doi.org\/10.1111\/jdv.19694","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9127_CR116","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.cell.2009.11.034","volume":"139","author":"Q Liu","year":"2009","unstructured":"Liu Q et al (2009) Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 139:1353\u20131365. https:\/\/doi.org\/10.1016\/j.cell.2009.11.034","journal-title":"Cell"},{"key":"9127_CR117","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/nn.2789","volume":"14","author":"SR Wilson","year":"2011","unstructured":"Wilson SR et al (2011) TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch. Nat Neurosci 14:595\u2013602. https:\/\/doi.org\/10.1038\/nn.2789","journal-title":"Nat Neurosci"},{"key":"9127_CR118","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1523\/jneurosci.4643-06.2007","volume":"27","author":"WS Shim","year":"2007","unstructured":"Shim WS et al (2007) TRPV1 mediates histamine-induced itching via the activation of phospholipase A2 and 12-lipoxygenase. J Neurosci 27:2331\u20132337. https:\/\/doi.org\/10.1523\/jneurosci.4643-06.2007","journal-title":"J Neurosci"},{"key":"9127_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810294","author":"L Beyer","year":"2022","unstructured":"Beyer L et al (2022) Histamine activates human eosinophils via H(2)R and H(4)R predominantly in atopic dermatitis patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms231810294","journal-title":"Int J Mol Sci"},{"key":"9127_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10091976","author":"CH Bang","year":"2021","unstructured":"Bang CH et al (2021) Production of IL-31 in CD45RO(+)CLA(+)H4R(+) t cells in atopic dermatitis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10091976","journal-title":"J Clin Med"},{"key":"9127_CR121","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.4049\/jimmunol.1300300","volume":"191","author":"MH Oh","year":"2013","unstructured":"Oh MH et al (2013) TRPA1-dependent pruritus in IL-13-induced chronic atopic dermatitis. J Immunol 191:5371\u20135382. https:\/\/doi.org\/10.4049\/jimmunol.1300300","journal-title":"J Immunol"},{"key":"9127_CR122","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/exd.14060","volume":"29","author":"ER Bray","year":"2020","unstructured":"Bray ER, Ch\u00e9ret J, Yosipovitch G, Paus R (2020) Schwann cells as underestimated, major players in human skin physiology and pathology. Exp Dermatol 29:93\u2013101. https:\/\/doi.org\/10.1111\/exd.14060","journal-title":"Exp Dermatol"},{"key":"9127_CR123","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1126\/science.aax6452","volume":"365","author":"H Abdo","year":"2019","unstructured":"Abdo H et al (2019) Specialized cutaneous Schwann cells initiate pain sensation. Science 365:695\u2013699. https:\/\/doi.org\/10.1126\/science.aax6452","journal-title":"Science"},{"key":"9127_CR124","doi-asserted-by":"publisher","unstructured":"Zhang W et al (2023) IL-13 Activates Cutaneous Schwann Cells to Promote CCL7-Dependent Pruritic Signaling in Atopic Dermatitis. J Invest Dermatol 143, 2322\u20132327.e2329 https:\/\/doi.org\/10.1016\/j.jid.2023.04.018","DOI":"10.1016\/j.jid.2023.04.018"},{"key":"9127_CR125","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/glia.23585","volume":"67","author":"JW Robering","year":"2019","unstructured":"Robering JW et al (2019) Lysophosphatidic acid activates satellite glia cells and Schwann cells. Glia 67:999\u20131012. https:\/\/doi.org\/10.1002\/glia.23585","journal-title":"Glia"},{"key":"9127_CR126","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/s41467-017-01739-2","volume":"8","author":"F De Logu","year":"2017","unstructured":"De Logu F et al (2017) Schwann cell TRPA1 mediates neuroinflammation that sustains macrophage-dependent neuropathic pain in mice. Nat Commun 8:1887. https:\/\/doi.org\/10.1038\/s41467-017-01739-2","journal-title":"Nat Commun"},{"key":"9127_CR127","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216527","volume":"14","author":"FL Rice","year":"2019","unstructured":"Rice FL et al (2019) The evolution and multi-molecular properties of NF1 cutaneous neurofibromas originating from C-fiber sensory endings and terminal Schwann cells at normal sites of sensory terminations in the skin. PLoS One 14:e0216527. https:\/\/doi.org\/10.1371\/journal.pone.0216527","journal-title":"PLoS One"},{"key":"9127_CR128","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/nm.3912","volume":"21","author":"M Shiratori-Hayashi","year":"2015","unstructured":"Shiratori-Hayashi M et al (2015) STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch. Nat Med 21:927\u2013931. https:\/\/doi.org\/10.1038\/nm.3912","journal-title":"Nat Med"},{"key":"9127_CR129","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.alit.2016.07.007","volume":"66","author":"M Tsuda","year":"2017","unstructured":"Tsuda M (2017) Spinal dorsal horn astrocytes: new players in chronic itch. Allergol Int 66:31\u201335. https:\/\/doi.org\/10.1016\/j.alit.2016.07.007","journal-title":"Allergol Int"},{"key":"9127_CR130","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s12272-022-01369-3","volume":"45","author":"B Yang","year":"2022","unstructured":"Yang B, Ryu JS, Rim C, Shin JU, Kwon MS (2022) Possible role of arginase 1 positive microglia on depressive\/anxiety-like behaviors in atopic dermatitis mouse model. Arch Pharm Res 45:11\u201328. https:\/\/doi.org\/10.1007\/s12272-022-01369-3","journal-title":"Arch Pharm Res"},{"key":"9127_CR131","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1038\/s41467-023-38264-4","volume":"14","author":"JN Li","year":"2023","unstructured":"Li JN et al (2023) Central medial thalamic nucleus dynamically participates in acute itch sensation and chronic itch-induced anxiety-like behavior in male mice. Nat Commun 14:2539. https:\/\/doi.org\/10.1038\/s41467-023-38264-4","journal-title":"Nat Commun"},{"key":"9127_CR132","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1097\/j.pain.0000000000001678","volume":"160","author":"AIM van Laarhoven","year":"2019","unstructured":"van Laarhoven AIM et al (2019) Itch sensitization? A systematic review of studies using quantitative sensory testing in patients with chronic itch. Pain 160:2661\u20132678. https:\/\/doi.org\/10.1097\/j.pain.0000000000001678","journal-title":"Pain"},{"key":"9127_CR133","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pain.2013.09.011","volume":"155","author":"T Akiyama","year":"2014","unstructured":"Akiyama T, Tominaga M, Takamori K, Carstens MI, Carstens E (2014) Roles of glutamate, substance P, and gastrin-releasing peptide as spinal neurotransmitters of histaminergic and nonhistaminergic itch. Pain 155:80\u201392. https:\/\/doi.org\/10.1016\/j.pain.2013.09.011","journal-title":"Pain"},{"key":"9127_CR134","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108025","volume":"170","author":"N Kiguchi","year":"2020","unstructured":"Kiguchi N et al (2020) GRP receptor and AMPA receptor cooperatively regulate itch-responsive neurons in the spinal dorsal horn. Neuropharmacology 170:108025. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108025","journal-title":"Neuropharmacology"},{"key":"9127_CR135","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/nn.2683","volume":"13","author":"T Liu","year":"2010","unstructured":"Liu T, Xu ZZ, Park CK, Berta T, Ji RR (2010) Toll-like receptor 7 mediates pruritus. Nat Neurosci 13:1460\u20131462. https:\/\/doi.org\/10.1038\/nn.2683","journal-title":"Nat Neurosci"},{"key":"9127_CR136","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1172\/jci45414","volume":"122","author":"T Liu","year":"2012","unstructured":"Liu T et al (2012) TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice. J Clin Invest 122:2195\u20132207. https:\/\/doi.org\/10.1172\/jci45414","journal-title":"J Clin Invest"},{"key":"9127_CR137","doi-asserted-by":"publisher","first-page":"103472","DOI":"10.1016\/j.redox.2024.103472","volume":"79","author":"L Zhang","year":"2025","unstructured":"Zhang L et al (2025) Molecular hydrogen reduces dermatitis-induced itch, diabetic itch and cholestatic itch by inhibiting spinal oxidative stress and synaptic plasticity via SIRT1-\u03b2-catenin pathway in mice. Redox Biol 79:103472. https:\/\/doi.org\/10.1016\/j.redox.2024.103472","journal-title":"Redox Biol"},{"key":"9127_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105886","volume":"167","author":"E Velasco","year":"2024","unstructured":"Velasco E et al (2024) Is chronic pain caused by central sensitization? A review and critical point of view. Neurosci Biobehav Rev 167:105886. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105886","journal-title":"Neurosci Biobehav Rev"},{"key":"9127_CR139","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101894","volume":"196","author":"TS Nelson","year":"2021","unstructured":"Nelson TS, Taylor BK (2021) Targeting spinal neuropeptide Y1 receptor-expressing interneurons to alleviate chronic pain and itch. Prog Neurobiol 196:101894. https:\/\/doi.org\/10.1016\/j.pneurobio.2020.101894","journal-title":"Prog Neurobiol"},{"key":"9127_CR140","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.neuron.2019.06.016","volume":"103","author":"H Pan","year":"2019","unstructured":"Pan H et al (2019) Identification of a spinal circuit for mechanical and persistent spontaneous itch. Neuron 103:1135\u20131149e1136. https:\/\/doi.org\/10.1016\/j.neuron.2019.06.016","journal-title":"Neuron"},{"key":"9127_CR141","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1093\/brain\/awaa430","volume":"144","author":"Z Wang","year":"2021","unstructured":"Wang Z et al (2021) Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition. Brain 144:665\u2013681. https:\/\/doi.org\/10.1093\/brain\/awaa430","journal-title":"Brain"},{"key":"9127_CR142","doi-asserted-by":"publisher","first-page":"115062","DOI":"10.1016\/j.celrep.2024.115062","volume":"43","author":"GY Wu","year":"2024","unstructured":"Wu GY et al (2024) An excitatory neural circuit for descending Inhibition of itch processing. Cell Rep 43:115062. https:\/\/doi.org\/10.1016\/j.celrep.2024.115062","journal-title":"Cell Rep"},{"key":"9127_CR143","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/j.cub.2024.02.060","volume":"34","author":"J Zheng","year":"2024","unstructured":"Zheng J et al (2024) An insular cortical circuit required for itch sensation and aversion. Curr Biol 34:1453\u20131468e1456. https:\/\/doi.org\/10.1016\/j.cub.2024.02.060","journal-title":"Curr Biol"},{"key":"9127_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16859-5","volume":"11","author":"XJ Chen","year":"2020","unstructured":"Chen XJ, Sun YG (2020) Central circuit mechanisms of itch. Nat Commun 11:3052. https:\/\/doi.org\/10.1038\/s41467-020-16859-5","journal-title":"Nat Commun"},{"key":"9127_CR145","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn6272","volume":"10","author":"SS Guo","year":"2024","unstructured":"Guo SS et al (2024) A thalamic nucleus reuniens-lateral septum-lateral hypothalamus circuit for comorbid anxiety-like behaviors in chronic itch. Sci Adv 10:eadn6272. https:\/\/doi.org\/10.1126\/sciadv.adn6272","journal-title":"Sci Adv"},{"key":"9127_CR146","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jaci.2019.09.034","volume":"145","author":"K Koga","year":"2020","unstructured":"Koga K et al (2020) Sensitization of spinal itch transmission neurons in a mouse model of chronic itch requires an astrocytic factor. J Allergy Clin Immunol 145:183\u2013191e110. https:\/\/doi.org\/10.1016\/j.jaci.2019.09.034","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR147","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jaci.2020.06.039","volume":"147","author":"M Shiratori-Hayashi","year":"2021","unstructured":"Shiratori-Hayashi M et al (2021) Astrocytic STAT3 activation and chronic itch require IP(3)R1\/TRPC-dependent Ca(2+) signals in mice. J Allergy Clin Immunol 147:1341\u20131353. https:\/\/doi.org\/10.1016\/j.jaci.2020.06.039","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR148","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.2249","volume":"64","author":"M Fabrazzo","year":"2021","unstructured":"Fabrazzo M et al (2021) A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa. Eur Psychiatry 64:e71. https:\/\/doi.org\/10.1192\/j.eurpsy.2021.2249","journal-title":"Eur Psychiatry"},{"key":"9127_CR149","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jaci.2020.04.024","volume":"145","author":"Z Celebi S\u00f6zener","year":"2020","unstructured":"Celebi S\u00f6zener Z, Cevhertas L, Nadeau K, Akdis M, Akdis CA (2020) Environmental factors in epithelial barrier dysfunction. J Allergy Clin Immunol 145:1517\u20131528. https:\/\/doi.org\/10.1016\/j.jaci.2020.04.024","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR150","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155891","volume":"156","author":"C Cayrol","year":"2022","unstructured":"Cayrol C, Girard JP (2022) Interleukin-33 (IL-33): a critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine. Cytokine 156:155891. https:\/\/doi.org\/10.1016\/j.cyto.2022.155891","journal-title":"Cytokine"},{"key":"9127_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154969","volume":"119","author":"YY Yang","year":"2023","unstructured":"Yang YY et al (2023) Antipruritic effects of geraniol on acute and chronic itch via modulating spinal GABA\/GRPR signaling. Phytomedicine 119:154969. https:\/\/doi.org\/10.1016\/j.phymed.2023.154969","journal-title":"Phytomedicine"},{"key":"9127_CR152","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-025-00981-8","author":"YG Sun","year":"2025","unstructured":"Sun YG (2025) Central neural circuits underlying itch sensation. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/s41583-025-00981-8","journal-title":"Nat Rev Neurosci"},{"key":"9127_CR153","doi-asserted-by":"publisher","unstructured":"Meng QT et al (2021) BNP facilitates NMB-encoded histaminergic itch via NPRC-NMBR crosstalk. Elife 10. https:\/\/doi.org\/10.7554\/eLife.71689","DOI":"10.7554\/eLife.71689"},{"key":"9127_CR154","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1152\/physiol.00007.2011","volume":"26","author":"J Jeffry","year":"2011","unstructured":"Jeffry J, Kim S, Chen ZF (2011) Itch signaling in the nervous system. Physiol (Bethesda) 26:286\u2013292. https:\/\/doi.org\/10.1152\/physiol.00007.2011","journal-title":"Physiol (Bethesda)"},{"key":"9127_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2022.100916","volume":"12","author":"WJ Lee","year":"2023","unstructured":"Lee WJ, Shim WS (2023) Rg3-enriched Korean red ginseng alleviates chloroquine-induced itch and dry skin pruritus in an MrgprA3-dependent manner in mice. Integr Med Res 12:100916. https:\/\/doi.org\/10.1016\/j.imr.2022.100916","journal-title":"Integr Med Res"},{"key":"9127_CR156","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1111\/bph.16072","volume":"180","author":"TC Fricke","year":"2023","unstructured":"Fricke TC et al (2023) Molecular mechanisms of MrgprA3-independent activation of the transient receptor potential ion channels TRPA1 and TRPV1 by chloroquine. Br J Pharmacol 180:2214\u20132229. https:\/\/doi.org\/10.1111\/bph.16072","journal-title":"Br J Pharmacol"},{"key":"9127_CR157","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/exd.14182","volume":"29","author":"Z Wang","year":"2020","unstructured":"Wang Z, Babina M (2020) MRGPRX2 signals its importance in cutaneous mast cell biology: does MRGPRX2 connect mast cells and atopic dermatitis? Exp Dermatol 29:1104\u20131111. https:\/\/doi.org\/10.1111\/exd.14182","journal-title":"Exp Dermatol"},{"key":"9127_CR158","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41590-020-0753-y","volume":"21","author":"JM Inclan-Rico","year":"2020","unstructured":"Inclan-Rico JM et al (2020) Basophils prime group 2 innate lymphoid cells for neuropeptide-mediated inhibition. Nat Immunol 21:1181\u20131193. https:\/\/doi.org\/10.1038\/s41590-020-0753-y","journal-title":"Nat Immunol"},{"key":"9127_CR159","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.immuni.2019.06.009","volume":"51","author":"H Nagashima","year":"2019","unstructured":"Nagashima H et al (2019) Neuropeptide CGRP limits group 2 innate lymphoid cell responses and constrains type 2 inflammation. Immunity 51:682\u2013695e686. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.009","journal-title":"Immunity"},{"key":"9127_CR160","doi-asserted-by":"publisher","first-page":"L971","DOI":"10.1152\/ajplung.00345.2005","volume":"290","author":"M Moriyama","year":"2006","unstructured":"Moriyama M et al (2006) The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. Am J Physiol Lung Cell Mol Physiol 290:L971\u2013977. https:\/\/doi.org\/10.1152\/ajplung.00345.2005","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"9127_CR161","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1615\/critrevimmunol.v32.i4.20","volume":"32","author":"N Mikami","year":"2012","unstructured":"Mikami N, Fukada S, Yamamoto H, Tsujikawa K (2012) Neuronal derivative mediators that regulate cutaneous inflammations. Crit Rev Immunol 32:307\u2013320. https:\/\/doi.org\/10.1615\/critrevimmunol.v32.i4.20","journal-title":"Crit Rev Immunol"},{"key":"9127_CR162","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adp6450","volume":"10","author":"NM Mroz","year":"2025","unstructured":"Mroz NM, Chiaranunt P, Molofsky AV, Molofsky AB (2025) Cross-regulation between the nervous system and type 2 immunity. Sci Immunol 10:eadp6450. https:\/\/doi.org\/10.1126\/sciimmunol.adp6450","journal-title":"Sci Immunol"},{"key":"9127_CR163","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15181","volume":"33","author":"HQ Qu","year":"2024","unstructured":"Qu HQ, Kao C, Hakonarson H (2024) Implications of the non-neuronal cholinergic system for therapeutic interventions of inflammatory skin diseases. Exp Dermatol 33:e15181. https:\/\/doi.org\/10.1111\/exd.15181","journal-title":"Exp Dermatol"},{"key":"9127_CR164","doi-asserted-by":"publisher","first-page":"e2501960122","DOI":"10.1073\/pnas.2501960122","volume":"122","author":"E Foffi","year":"2025","unstructured":"Foffi E et al (2025) B cell-derived acetylcholine mitigates skin inflammation in mice through \u03b19 nicotinic acetylcholine receptor-mediated signaling. Proc Natl Acad Sci U S A 122:e2501960122. https:\/\/doi.org\/10.1073\/pnas.2501960122","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9127_CR165","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/bf02505049","volume":"288","author":"J Viac","year":"1996","unstructured":"Viac J et al (1996) Substance P and keratinocyte activation markers: an in vitro approach. Arch Dermatol Res 288:85\u201390. https:\/\/doi.org\/10.1007\/bf02505049","journal-title":"Arch Dermatol Res"},{"key":"9127_CR166","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.regpep.2013.08.001","volume":"186","author":"X Shi","year":"2013","unstructured":"Shi X, Wang L, Clark JD, Kingery WS (2013) Keratinocytes express cytokines and nerve growth factor in response to neuropeptide activation of the ERK1\/2 and JNK MAPK transcription pathways. Regul Pept 186:92\u2013103. https:\/\/doi.org\/10.1016\/j.regpep.2013.08.001","journal-title":"Regul Pept"},{"key":"9127_CR167","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215424","author":"M Furue","year":"2019","unstructured":"Furue M, Hashimoto-Hachiya A, Tsuji G (2019) Aryl hydrocarbon receptor in atopic dermatitis and psoriasis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20215424","journal-title":"Int J Mol Sci"},{"key":"9127_CR168","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/j.1365-2133.1989.tb08209.x","volume":"121","author":"A Giannetti","year":"1989","unstructured":"Giannetti A, Girolomoni G (1989) Skin reactivity to neuropeptides in atopic dermatitis. Br J Dermatol 121:681\u2013688. https:\/\/doi.org\/10.1111\/j.1365-2133.1989.tb08209.x","journal-title":"Br J Dermatol"},{"key":"9127_CR169","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/jid.2012.464","volume":"133","author":"D Roggenkamp","year":"2013","unstructured":"Roggenkamp D et al (2013) Epidermal nerve fibers modulate keratinocyte growth via neuropeptide signaling in an innervated skin model. J Invest Dermatol 133:1620\u20131628. https:\/\/doi.org\/10.1038\/jid.2012.464","journal-title":"J Invest Dermatol"},{"key":"9127_CR170","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/j.pain.0000000000000172","volume":"156","author":"T Akiyama","year":"2015","unstructured":"Akiyama T et al (2015) A central role for spinal dorsal horn neurons that express neurokinin-1 receptors in chronic itch. Pain 156:1240\u20131246. https:\/\/doi.org\/10.1097\/j.pain.0000000000000172","journal-title":"Pain"},{"key":"9127_CR171","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/exd.13421","volume":"27","author":"H Choi","year":"2018","unstructured":"Choi H et al (2018) Manifestation of atopic dermatitis-like skin in TNCB-induced NC\/Nga mice is ameliorated by topical treatment of substance P, possibly through Blockade of allergic inflammation. Exp Dermatol 27:396\u2013402. https:\/\/doi.org\/10.1111\/exd.13421","journal-title":"Exp Dermatol"},{"key":"9127_CR172","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/eji.201444553","volume":"44","author":"M Baliu-Piqu\u00e9","year":"2014","unstructured":"Baliu-Piqu\u00e9 M, Jusek G, Holzmann B (2014) Neuroimmunological communication via CGRP promotes the development of a regulatory phenotype in TLR4-stimulated macrophages. Eur J Immunol 44:3708\u20133716. https:\/\/doi.org\/10.1002\/eji.201444553","journal-title":"Eur J Immunol"},{"key":"9127_CR173","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/363159a0","volume":"363","author":"J Hosoi","year":"1993","unstructured":"Hosoi J et al (1993) Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 363:159\u2013163. https:\/\/doi.org\/10.1038\/363159a0","journal-title":"Nature"},{"key":"9127_CR174","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1046\/j.1365-2249.1997.4111309.x","volume":"109","author":"Y Kawaguchi","year":"1997","unstructured":"Kawaguchi Y et al (1997) Reduction of the DTH response is related to morphological changes of Langerhans cells in mice exposed to acute immobilization stress. Clin Exp Immunol 109:397\u2013401. https:\/\/doi.org\/10.1046\/j.1365-2249.1997.4111309.x","journal-title":"Clin Exp Immunol"},{"key":"9127_CR175","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.immuni.2025.03.018","volume":"58","author":"BS Kim","year":"2025","unstructured":"Kim BS, Artis D (2025) The sensory neuroimmune frontier. Immunity 58:1033\u20131039. https:\/\/doi.org\/10.1016\/j.immuni.2025.03.018","journal-title":"Immunity"},{"key":"9127_CR176","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cytogfr.2017.09.002","volume":"38","author":"AK Verma","year":"2017","unstructured":"Verma AK, Manohar M, Upparahalli Venkateshaiah S, Mishra A (2017) Neuroendocrine cells derived chemokine vasoactive intestinal polypeptide (VIP) in allergic diseases. Cytokine Growth Factor Rev 38:37\u201348. https:\/\/doi.org\/10.1016\/j.cytogfr.2017.09.002","journal-title":"Cytokine Growth Factor Rev"},{"key":"9127_CR177","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s0923-1811(03)00004-5","volume":"31","author":"N Umemoto","year":"2003","unstructured":"Umemoto N et al (2003) Serum levels of vasoactive intestinal peptide are elevated in patients with atopic dermatitis. J Dermatol Sci 31:161\u2013164. https:\/\/doi.org\/10.1016\/s0923-1811(03)00004-5","journal-title":"J Dermatol Sci"},{"key":"9127_CR178","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s004030050290","volume":"290","author":"R Rukwied","year":"1998","unstructured":"Rukwied R, Heyer G (1998) Cutaneous reactions and sensations after intracutaneous injection of vasoactive intestinal polypeptide and acetylcholine in atopic eczema patients and healthy controls. Arch Dermatol Res 290:198\u2013204. https:\/\/doi.org\/10.1007\/s004030050290","journal-title":"Arch Dermatol Res"},{"key":"9127_CR179","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s10194-010-0214-3","volume":"11","author":"HW Schytz","year":"2010","unstructured":"Schytz HW, Holst H, Arendt-Nielsen L, Olesen J, Ashina M (2010) Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP. J Headache Pain 11:309\u2013316. https:\/\/doi.org\/10.1007\/s10194-010-0214-3","journal-title":"J Headache Pain"},{"key":"9127_CR180","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/j.1365-2133.1997.tb01552.x","volume":"137","author":"DJ Gordon","year":"1997","unstructured":"Gordon DJ, Ostlere LS, Holden CA (1997) Neuropeptide modulation of Th1 and Th2 cytokines in peripheral blood mononuclear leucocytes in atopic dermatitis and non-atopic controls. Br J Dermatol 137:921\u2013927","journal-title":"Br J Dermatol"},{"key":"9127_CR181","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00281-018-0675-z","volume":"40","author":"JE Choi","year":"2018","unstructured":"Choi JE, Di Nardo A (2018) Skin neurogenic inflammation. Semin Immunopathol 40:249\u2013259. https:\/\/doi.org\/10.1007\/s00281-018-0675-z","journal-title":"Semin Immunopathol"},{"key":"9127_CR182","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s12031-022-01968-1","volume":"72","author":"ST Broome","year":"2022","unstructured":"Broome ST, Musumeci G, Castorina A (2022) PACAP and VIP mitigate Rotenone-induced inflammation in BV-2 microglial cells. J Mol Neurosci 72:2163\u20132175. https:\/\/doi.org\/10.1007\/s12031-022-01968-1","journal-title":"J Mol Neurosci"},{"key":"9127_CR183","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/jcp.21831","volume":"221","author":"A Nagata","year":"2009","unstructured":"Nagata A et al (2009) cAMP activation by PACAP\/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells. J Cell Physiol 221:75\u201383. https:\/\/doi.org\/10.1002\/jcp.21831","journal-title":"J Cell Physiol"},{"key":"9127_CR184","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/eji.201141958","volume":"42","author":"W Ding","year":"2012","unstructured":"Ding W et al (2012) Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells. Eur J Immunol 42:901\u2013911. https:\/\/doi.org\/10.1002\/eji.201141958","journal-title":"Eur J Immunol"},{"key":"9127_CR185","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1067\/mai.2003.1477","volume":"111","author":"DA Groneberg","year":"2003","unstructured":"Groneberg DA et al (2003) Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J Allergy Clin Immunol 111:1099\u20131105. https:\/\/doi.org\/10.1067\/mai.2003.1477","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR186","doi-asserted-by":"publisher","first-page":"R317","DOI":"10.1186\/ar999","volume":"5","author":"AD Foey","year":"2003","unstructured":"Foey AD et al (2003) Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis. Arthritis Res Ther 5:R317\u2013328. https:\/\/doi.org\/10.1186\/ar999","journal-title":"Arthritis Res Ther"},{"key":"9127_CR187","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.peptides.2008.01.019","volume":"29","author":"A Arranz","year":"2008","unstructured":"Arranz A, Juarranz Y, Leceta J, Gomariz RP, Mart\u00ednez C (2008) VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4. Peptides 29:948\u2013956. https:\/\/doi.org\/10.1016\/j.peptides.2008.01.019","journal-title":"Peptides"},{"key":"9127_CR188","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1046\/j.1523-1747.2001.01306.x","volume":"116","author":"M Kakurai","year":"2001","unstructured":"Kakurai M et al (2001) Vasoactive intestinal peptide regulates its receptor expression and functions of human keratinocytes via type I vasoactive intestinal peptide receptors. J Invest Dermatol 116:743\u2013749. https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01306.x","journal-title":"J Invest Dermatol"},{"key":"9127_CR189","doi-asserted-by":"publisher","unstructured":"Meixiong J et al (2019) Activation of Mast-Cell-Expressed Mas-Related G-Protein-Coupled Receptors Drives Non-histaminergic Itch. Immunity 50, 1163\u20131171.e1165 https:\/\/doi.org\/10.1016\/j.immuni.2019.03.013","DOI":"10.1016\/j.immuni.2019.03.013"},{"key":"9127_CR190","doi-asserted-by":"publisher","first-page":"357","DOI":"10.33549\/physiolres.933269","volume":"65","author":"P Mrozkova","year":"2016","unstructured":"Mrozkova P, Palecek J, Spicarova D (2016) The role of protease-activated receptor type 2 in nociceptive signaling and pain. Physiol Res 65:357\u2013367. https:\/\/doi.org\/10.33549\/physiolres.933269","journal-title":"Physiol Res"},{"key":"9127_CR191","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1600-0625.1998.tb00307.x","volume":"7","author":"T Scholzen","year":"1998","unstructured":"Scholzen T et al (1998) Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 7:81\u201396. https:\/\/doi.org\/10.1111\/j.1600-0625.1998.tb00307.x","journal-title":"Exp Dermatol"},{"key":"9127_CR192","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1468-3083.2007.02399.x","volume":"22","author":"J Salomon","year":"2008","unstructured":"Salomon J, Baran E (2008) The role of selected neuropeptides in pathogenesis of atopic dermatitis. J Eur Acad Dermatol Venereol 22:223\u2013228. https:\/\/doi.org\/10.1111\/j.1468-3083.2007.02399.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9127_CR193","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0923-1811(03)00155-5","volume":"33","author":"M Katsuno","year":"2003","unstructured":"Katsuno M et al (2003) Neuropeptides concentrations in the skin of a murine (NC\/Nga mice) model of atopic dermatitis. J Dermatol Sci 33:55\u201365. https:\/\/doi.org\/10.1016\/s0923-1811(03)00155-5","journal-title":"J Dermatol Sci"},{"key":"9127_CR194","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s004030000149","volume":"292","author":"M Toyoda","year":"2000","unstructured":"Toyoda M, Makino T, Kagoura M, Morohashi M (2000) Immunolocalization of substance P in human skin mast cells. Arch Dermatol Res 292:418\u2013421. https:\/\/doi.org\/10.1007\/s004030000149","journal-title":"Arch Dermatol Res"},{"key":"9127_CR195","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1006\/bbrc.1999.1285","volume":"263","author":"S Bae","year":"1999","unstructured":"Bae S, Matsunaga Y, Tanaka Y, Katayama I (1999) Autocrine induction of substance P mRNA and peptide in cultured normal human keratinocytes. Biochem Biophys Res Commun 263:327\u2013333. https:\/\/doi.org\/10.1006\/bbrc.1999.1285","journal-title":"Biochem Biophys Res Commun"},{"key":"9127_CR196","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/atvbaha.119.313800","volume":"40","author":"D Cao","year":"2020","unstructured":"Cao D et al (2020) MicroRNA-126-3p inhibits angiogenic function of human lung microvascular endothelial cells via LAT1 (L-Type amino acid transporter 1)-Mediated mTOR (Mammalian target of Rapamycin) signaling. Arterioscler Thromb Vasc Biol 40:1195\u20131206. https:\/\/doi.org\/10.1161\/atvbaha.119.313800","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9127_CR197","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/s0143-4179(96)90082-7","volume":"30","author":"T Tsuchiya","year":"1996","unstructured":"Tsuchiya T, Kishimoto J, Granstein RD, Nakayama Y (1996) Quantitative analysis of cutaneous calcitonin gene-related peptide content in response to acute cutaneous mechanical or thermal stimuli and immobilization-induced stress in rats. Neuropeptides 30:149\u2013157. https:\/\/doi.org\/10.1016\/s0143-4179(96)90082-7","journal-title":"Neuropeptides"},{"key":"9127_CR198","doi-asserted-by":"publisher","first-page":"8617","DOI":"10.1016\/j.biomaterials.2010.07.079","volume":"31","author":"H Kohara","year":"2010","unstructured":"Kohara H, Tajima S, Yamamoto M, Tabata Y (2010) Angiogenesis induced by controlled release of neuropeptide substance P. Biomaterials 31:8617\u20138625. https:\/\/doi.org\/10.1016\/j.biomaterials.2010.07.079","journal-title":"Biomaterials"},{"key":"9127_CR199","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/exd.14723","volume":"32","author":"Y Zheng","year":"2023","unstructured":"Zheng Y et al (2023) Hydroquinone-induced skin irritant reaction could be achieved by activating mast cells via mas-related G protein-coupled receptor X2. Exp Dermatol 32:436\u2013446. https:\/\/doi.org\/10.1111\/exd.14723","journal-title":"Exp Dermatol"},{"key":"9127_CR200","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s41590-019-0493-z","volume":"20","author":"N Serhan","year":"2019","unstructured":"Serhan N et al (2019) House dust mites activate nociceptor-mast cell clusters to drive type 2 skin inflammation. Nat Immunol 20:1435\u20131443. https:\/\/doi.org\/10.1038\/s41590-019-0493-z","journal-title":"Nat Immunol"},{"key":"9127_CR201","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22105318","author":"C Chompunud Na Ayudhya","year":"2021","unstructured":"Chompunud Na Ayudhya C, Amponnawarat A, Ali H (2021) Substance P serves as a balanced agonist for MRGPRX2 and a single tyrosine residue is required for \u03b2-arrestin recruitment and receptor internalization. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22105318","journal-title":"Int J Mol Sci"},{"key":"9127_CR202","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1033794","volume":"13","author":"M Bawazir","year":"2022","unstructured":"Bawazir M, Amponnawarat A, Hui Y, Oskeritzian CA, Ali H (2022) Inhibition of MRGPRX2 but not Fc\u03b5RI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist. Front Immunol 13:1033794. https:\/\/doi.org\/10.3389\/fimmu.2022.1033794","journal-title":"Front Immunol"},{"key":"9127_CR203","doi-asserted-by":"publisher","first-page":"128485","DOI":"10.1016\/j.bmcl.2021.128485","volume":"56","author":"K Iio","year":"2022","unstructured":"Iio K et al (2022) Synthesis of unnatural morphinan compounds to induce itch-like behaviors in mice: towards the development of MRGPRX2 selective ligands. Bioorg Med Chem Lett 56:128485. https:\/\/doi.org\/10.1016\/j.bmcl.2021.128485","journal-title":"Bioorg Med Chem Lett"},{"key":"9127_CR204","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/08923973.2023.2253988","volume":"46","author":"S Abdelhadi","year":"2024","unstructured":"Abdelhadi S et al (2024) Expression of calcitonin gene-related peptide in atopic dermatitis and correlation with distress. Immunopharmacol Immunotoxicol 46:67\u201372. https:\/\/doi.org\/10.1080\/08923973.2023.2253988","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"9127_CR205","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00403-002-0378-z","volume":"295","author":"A J\u00e4rvikallio","year":"2003","unstructured":"J\u00e4rvikallio A, Harvima IT, Naukkarinen A (2003) Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 295:2\u20137. https:\/\/doi.org\/10.1007\/s00403-002-0378-z","journal-title":"Arch Dermatol Res"},{"key":"9127_CR206","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jaci.2010.10.028","volume":"127","author":"AB Kay","year":"2011","unstructured":"Kay AB (2011) Calcitonin gene-related peptide- and vascular endothelial growth factor-positive inflammatory cells in late-phase allergic skin reactions in atopic subjects. J Allergy Clin Immunol 127:232\u2013237. https:\/\/doi.org\/10.1016\/j.jaci.2010.10.028","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR207","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1021\/acschembio.6b00616","volume":"11","author":"BM Manning","year":"2016","unstructured":"Manning BM, Gruba SM, Meyer AF, Haynes CL (2016) Neuropeptide-induced mast cell degranulation and characterization of signaling modulation in response to IgE conditioning. ACS Chem Biol 11:3077\u20133083. https:\/\/doi.org\/10.1021\/acschembio.6b00616","journal-title":"ACS Chem Biol"},{"key":"9127_CR208","doi-asserted-by":"publisher","first-page":"108342","DOI":"10.1016\/j.intimp.2021.108342","volume":"101","author":"D Che","year":"2021","unstructured":"Che D et al (2021) Action of substance P and PAMP(9\u201320) on different excitation sites of MRGPRX2 induces differences in mast cell activation. Int Immunopharmacol 101:108342. https:\/\/doi.org\/10.1016\/j.intimp.2021.108342","journal-title":"Int Immunopharmacol"},{"key":"9127_CR209","doi-asserted-by":"publisher","first-page":"696784","DOI":"10.3389\/fimmu.2021.696784","volume":"12","author":"J Meng","year":"2021","unstructured":"Meng J et al (2021) Th2 modulation of transient receptor potential channels: an unmet therapeutic intervention for atopic dermatitis. Front Immunol 12:696784. https:\/\/doi.org\/10.3389\/fimmu.2021.696784","journal-title":"Front Immunol"},{"key":"9127_CR210","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/j.pain.0000000000000134","volume":"156","author":"S Wang","year":"2015","unstructured":"Wang S, Joseph J, Ro JY, Chung MK (2015) Modality-specific mechanisms of protein kinase C-induced hypersensitivity of TRPV1: S800 is a polymodal sensitization site. Pain 156:931\u2013941. https:\/\/doi.org\/10.1097\/j.pain.0000000000000134","journal-title":"Pain"},{"key":"9127_CR211","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/bph.15971","volume":"180","author":"C K\u00f6nig","year":"2023","unstructured":"K\u00f6nig C, Ebersberger A, Eitner A, Wetzker R, Schaible HG (2023) Prostaglandin EP3 receptor activation is antinociceptive in sensory neurons via PI3K\u03b3, AMPK and GRK2. Br J Pharmacol 180:441\u2013458. https:\/\/doi.org\/10.1111\/bph.15971","journal-title":"Br J Pharmacol"},{"key":"9127_CR212","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-7-70","volume":"7","author":"OK Melemedjian","year":"2011","unstructured":"Melemedjian OK et al (2011) Targeting adenosine monophosphate-activated protein kinase (AMPK) in preclinical models reveals a potential mechanism for the treatment of neuropathic pain. Mol Pain 7:70. https:\/\/doi.org\/10.1186\/1744-8069-7-70","journal-title":"Mol Pain"},{"key":"9127_CR213","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.brainresbull.2020.12.014","volume":"168","author":"L Lv","year":"2021","unstructured":"Lv L, Bai D, Ma Y, Liu K, Ma Y (2021) The PGE2 receptor EP3 plays a positive role in the activation of hypothalamic-pituitary-adrenal axis and neuronal activity in the hypothalamus under immobilization stress. Brain Res Bull 168:45\u201351. https:\/\/doi.org\/10.1016\/j.brainresbull.2020.12.014","journal-title":"Brain Res Bull"},{"key":"9127_CR214","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1124\/jpet.105.091645","volume":"315","author":"N Kanda","year":"2005","unstructured":"Kanda N, Koike S, Watanabe S (2005) Prostaglandin E2 enhances neurotrophin-4 production via EP3 receptor in human keratinocytes. J Pharmacol Exp Ther 315:796\u2013804. https:\/\/doi.org\/10.1124\/jpet.105.091645","journal-title":"J Pharmacol Exp Ther"},{"key":"9127_CR215","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1007\/s10753-014-9999-6","volume":"38","author":"Q Fu","year":"2015","unstructured":"Fu Q et al (2015) Protease-activated receptor 4: a critical participator in inflammatory response. Inflammation 38:886\u2013895. https:\/\/doi.org\/10.1007\/s10753-014-9999-6","journal-title":"Inflammation"},{"key":"9127_CR216","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.neuroscience.2011.06.085","volume":"193","author":"Y Chen","year":"2011","unstructured":"Chen Y, Yang C, Wang ZJ (2011) Proteinase-activated receptor 2 sensitizes transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential Ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 193:440\u2013451. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.06.085","journal-title":"Neuroscience"},{"key":"9127_CR217","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2014.00067","volume":"5","author":"P Zhao","year":"2014","unstructured":"Zhao P, Metcalf M, Bunnett NW (2014) Biased signaling of protease-activated receptors. Front Endocrinol (Lausanne) 5:67. https:\/\/doi.org\/10.3389\/fendo.2014.00067","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9127_CR218","doi-asserted-by":"publisher","DOI":"10.3390\/biom11081166","author":"J Wilzopolski","year":"2021","unstructured":"Wilzopolski J (2021) TRPV1 and TRPA1 channels are both involved downstream of histamine-induced itch. Biomolecules. https:\/\/doi.org\/10.3390\/biom11081166","journal-title":"Biomolecules"},{"key":"9127_CR219","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1111\/bph.16012","volume":"180","author":"PY Sun","year":"2023","unstructured":"Sun PY et al (2023) Lidocaine alleviates inflammation and pruritus in atopic dermatitis by blocking different population of sensory neurons. Br J Pharmacol 180:1339\u20131361. https:\/\/doi.org\/10.1111\/bph.16012","journal-title":"Br J Pharmacol"},{"key":"9127_CR220","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2022.184014","volume":"1864","author":"R Afzal","year":"2022","unstructured":"Afzal R, Shim WS (2022) Activation of serotonin receptor 2 by glucosylsphingosine can be enhanced by TRPA1 but not TRPV1: implication of a novel glucosylsphingosine-mediated itch pathway. Biochim Biophys Acta Biomembr 1864:184014. https:\/\/doi.org\/10.1016\/j.bbamem.2022.184014","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"9127_CR221","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.cell.2013.08.057","volume":"155","author":"SR Wilson","year":"2013","unstructured":"Wilson SR et al (2013) The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155:285\u2013295. https:\/\/doi.org\/10.1016\/j.cell.2013.08.057","journal-title":"Cell"},{"key":"9127_CR222","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jaci.2013.10.048","volume":"133","author":"F Cevikbas","year":"2014","unstructured":"Cevikbas F et al (2014) A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol 133:448\u2013460. https:\/\/doi.org\/10.1016\/j.jaci.2013.10.048","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR223","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jaci.2023.08.038","volume":"153","author":"AM Trier","year":"2024","unstructured":"Trier AM et al (2024) IL-33 potentiates histaminergic itch. J Allergy Clin Immunol 153:852\u2013859e853. https:\/\/doi.org\/10.1016\/j.jaci.2023.08.038","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR224","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/all.12633","volume":"70","author":"MK Aktar","year":"2015","unstructured":"Aktar MK, Kido-Nakahara M, Furue M, Nakahara T (2015) Mutual upregulation of endothelin-1 and IL-25 in atopic dermatitis. Allergy 70:846\u2013854. https:\/\/doi.org\/10.1111\/all.12633","journal-title":"Allergy"},{"key":"9127_CR225","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1080\/09546634.2020.1836310","volume":"33","author":"CRS Prakoeswa","year":"2022","unstructured":"Prakoeswa CRS et al (2022) Beneficial effect of Lactobacillus plantarum IS-10506 supplementation in adults with atopic dermatitis: a randomized controlled trial. J Dermatolog Treat 33:1491\u20131498. https:\/\/doi.org\/10.1080\/09546634.2020.1836310","journal-title":"J Dermatolog Treat"},{"key":"9127_CR226","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00108","volume":"6","author":"M Talagas","year":"2019","unstructured":"Talagas M, Misery L (2019) Role of keratinocytes in sensitive skin. Front Med (Lausanne) 6:108. https:\/\/doi.org\/10.3389\/fmed.2019.00108","journal-title":"Front Med (Lausanne)"},{"key":"9127_CR227","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.lfs.2012.03.020","volume":"91","author":"LO Gomes","year":"2012","unstructured":"Gomes LO, Hara DB, Rae GA (2012) Endothelin-1 induces itch and pain in the mouse cheek model. Life Sci 91:628\u2013633. https:\/\/doi.org\/10.1016\/j.lfs.2012.03.020","journal-title":"Life Sci"},{"key":"9127_CR228","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/jid.2010.361","volume":"131","author":"C Moriya","year":"2011","unstructured":"Moriya C et al (2011) Expression of matrix metalloproteinase-13 is controlled by IL-13 via PI3K\/Akt3 and PKC-\u03b4 in normal human dermal fibroblasts. J Invest Dermatol 131:655\u2013661. https:\/\/doi.org\/10.1038\/jid.2010.361","journal-title":"J Invest Dermatol"},{"key":"9127_CR229","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1068260","volume":"13","author":"IH Huang","year":"2022","unstructured":"Huang IH, Chung WH, Wu PC, Chen CB (2022) JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review. Front Immunol 13:1068260. https:\/\/doi.org\/10.3389\/fimmu.2022.1068260","journal-title":"Front Immunol"},{"key":"9127_CR230","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/jid.2012.44","volume":"132","author":"D Roggenkamp","year":"2012","unstructured":"Roggenkamp D et al (2012) Atopic keratinocytes induce increased neurite outgrowth in a coculture model of porcine dorsal root ganglia neurons and human skin cells. J Invest Dermatol 132:1892\u20131900. https:\/\/doi.org\/10.1038\/jid.2012.44","journal-title":"J Invest Dermatol"},{"key":"9127_CR231","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jid.2024.01.017","volume":"144","author":"H Yeo","year":"2024","unstructured":"Yeo H et al (2024) The EGR1-Artemin axis in keratinocytes enhances the innervation of epidermal sensory neurons during skin inflammation induced by house dust mite extract from dermatophagoidesfarinae. J Invest Dermatol 144:1817\u20131828e1817. https:\/\/doi.org\/10.1016\/j.jid.2024.01.017","journal-title":"J Invest Dermatol"},{"key":"9127_CR232","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1038\/s41598-022-05811-w","volume":"12","author":"HJ Solinski","year":"2022","unstructured":"Solinski HJ, Rukwied R, Schmelz M (2022) Publisher correction: microinjection of pruritogens in NGF-sensitized human skin. Sci Rep 12:1566. https:\/\/doi.org\/10.1038\/s41598-022-05811-w","journal-title":"Sci Rep"},{"key":"9127_CR233","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00935-x","volume":"11","author":"HJ Solinski","year":"2021","unstructured":"Solinski HJ, Rukwied R, Schmelz M (2021) Microinjection of pruritogens in NGF-sensitized human skin. Sci Rep 11:21490. https:\/\/doi.org\/10.1038\/s41598-021-00935-x","journal-title":"Sci Rep"},{"key":"9127_CR234","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1570159x21666230808111908","volume":"22","author":"MA Schumacher","year":"2024","unstructured":"Schumacher MA (2024) Peripheral neuroinflammation and pain: how acute pain becomes chronic. Curr Neuropharmacol 22:6\u201314. https:\/\/doi.org\/10.2174\/1570159x21666230808111908","journal-title":"Curr Neuropharmacol"},{"key":"9127_CR235","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.expneurol.2005.10.006","volume":"197","author":"AM Skoff","year":"2006","unstructured":"Skoff AM, Adler JE (2006) Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors. Exp Neurol 197:430\u2013436. https:\/\/doi.org\/10.1016\/j.expneurol.2005.10.006","journal-title":"Exp Neurol"},{"key":"9127_CR236","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jneuroim.2004.12.019","volume":"161","author":"DA Groneberg","year":"2005","unstructured":"Groneberg DA et al (2005) Gene expression and regulation of nerve growth factor in atopic dermatitis mast cells and the human mast cell line-1. J Neuroimmunol 161:87\u201392. https:\/\/doi.org\/10.1016\/j.jneuroim.2004.12.019","journal-title":"J Neuroimmunol"},{"key":"9127_CR237","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6673-4-8","volume":"4","author":"D Quarcoo","year":"2009","unstructured":"Quarcoo D, Fischer TC, Peckenschneider N, Groneberg DA, Welker P (2009) High abundances of neurotrophin 3 in atopic dermatitis mast cell. J Occup Med Toxicol 4:8. https:\/\/doi.org\/10.1186\/1745-6673-4-8","journal-title":"J Occup Med Toxicol"},{"key":"9127_CR238","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/j.1365-4632.2009.03968.x","volume":"48","author":"HO Kim","year":"2009","unstructured":"Kim HO, Lee CH, Ahn HK, Park CW (2009) Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis. Int J Dermatol 48:431\u2013438. https:\/\/doi.org\/10.1111\/j.1365-4632.2009.03968.x","journal-title":"Int J Dermatol"},{"key":"9127_CR239","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1046\/j.1523-1747.2000.00974.x","volume":"114","author":"M Grewe","year":"2000","unstructured":"Grewe M, Vogelsang K, Ruzicka T, Stege H, Krutmann J (2000) Neurotrophin-4 production by human epidermal keratinocytes: increased expression in atopic dermatitis. J Invest Dermatol 114:1108\u20131112. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00974.x","journal-title":"J Invest Dermatol"},{"key":"9127_CR240","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.0906-6705.2004.00115.x","volume":"13","author":"M Metz","year":"2004","unstructured":"Metz M et al (2004) Neurotrophin-3 regulates mast cell functions in neonatal mouse skin. Exp Dermatol 13:273\u2013281. https:\/\/doi.org\/10.1111\/j.0906-6705.2004.00115.x","journal-title":"Exp Dermatol"},{"key":"9127_CR241","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jaci.2005.02.007","volume":"115","author":"U Raap","year":"2005","unstructured":"Raap U et al (2005) Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. J Allergy Clin Immunol 115:1268\u20131275. https:\/\/doi.org\/10.1016\/j.jaci.2005.02.007","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR242","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2133.2006.07636.x","volume":"156","author":"N Takano","year":"2007","unstructured":"Takano N, Sakurai T, Ohashi Y, Kurachi M (2007) Effects of high-affinity nerve growth factor receptor inhibitors on symptoms in the NC\/Nga mouse atopic dermatitis model. Br J Dermatol 156:241\u2013246. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07636.x","journal-title":"Br J Dermatol"},{"key":"9127_CR243","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1254\/jphs.fp0050564","volume":"99","author":"N Takano","year":"2005","unstructured":"Takano N, Sakurai T, Kurachi M (2005) Effects of anti-nerve growth factor antibody on symptoms in the NC\/Nga mouse, an atopic dermatitis model. J Pharmacol Sci 99:277\u2013286. https:\/\/doi.org\/10.1254\/jphs.fp0050564","journal-title":"J Pharmacol Sci"},{"key":"9127_CR244","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105121","volume":"103","author":"CO Park","year":"2024","unstructured":"Park CO, Kim SM, Lee KH, Bieber T (2024) Biomarkers for phenotype-endotype relationship in atopic dermatitis: a critical review. EBioMedicine 103:105121. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105121","journal-title":"EBioMedicine"},{"key":"9127_CR245","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaci.2022.07.021","volume":"151","author":"JW Hui-Beckman","year":"2023","unstructured":"Hui-Beckman JW, Goleva E, Berdyshev E, Leung DYM (2023) Endotypes of atopic dermatitis and food allergy. J Allergy Clin Immunol 151:26\u201328. https:\/\/doi.org\/10.1016\/j.jaci.2022.07.021","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR246","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jaci.2025.02.029","volume":"156","author":"N Fyhrquist","year":"2025","unstructured":"Fyhrquist N, Yang Y, Karisola P, Alenius H (2025) Endotypes of atopic dermatitis. J Allergy Clin Immunol 156:24-40.e24. https:\/\/doi.org\/10.1016\/j.jaci.2025.02.029","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR247","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1749-6632.2012.06647.x","volume":"1262","author":"EM Peters","year":"2012","unstructured":"Peters EM, Liezmann C, Klapp BF, Kruse J (2012) The neuroimmune connection interferes with tissue regeneration and chronic inflammatory disease in the skin. Ann N Y Acad Sci 1262:118\u2013126. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06647.x","journal-title":"Ann N Y Acad Sci"},{"key":"9127_CR248","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbi.2023.12.005","volume":"116","author":"H Zhang","year":"2024","unstructured":"Zhang H et al (2024) Role of stress in skin diseases: A neuroendocrine-immune interaction view. Brain Behav Immun 116:286\u2013302. https:\/\/doi.org\/10.1016\/j.bbi.2023.12.005","journal-title":"Brain Behav Immun"},{"key":"9127_CR249","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-1160-7","volume":"17","author":"S Lee","year":"2017","unstructured":"Lee S, Shin A (2017) Association of atopic dermatitis with depressive symptoms and suicidal behaviors among adolescents in Korea: the 2013 Korean Youth Risk Behavior Survey. BMC Psychiatry 17:3. https:\/\/doi.org\/10.1186\/s12888-016-1160-7","journal-title":"BMC Psychiatry"},{"key":"9127_CR250","doi-asserted-by":"publisher","first-page":"97","DOI":"10.12932\/ap-231022-1484","volume":"41","author":"V Gonzalez-Uribe","year":"2023","unstructured":"Gonzalez-Uribe V, de la Vidaurri- Cruz H, Gomez-Nu\u00f1ez A, Leyva-Calderon JA, Mojica-Gonzalez ZS (2023) Comorbidities & burden of disease in atopic dermatitis. Asian Pac J Allergy Immunol 41:97\u2013105. https:\/\/doi.org\/10.12932\/ap-231022-1484","journal-title":"Asian Pac J Allergy Immunol"},{"key":"9127_CR251","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/bjd.16735","volume":"179","author":"G Schneider","year":"2018","unstructured":"Schneider G et al (2018) Are patients with chronic pruritus more susceptible to social stress than healthy controls? An experimental case-control study. Br J Dermatol 179:1174\u20131176. https:\/\/doi.org\/10.1111\/bjd.16735","journal-title":"Br J Dermatol"},{"key":"9127_CR252","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5021\/ad.22.035","volume":"35","author":"L L\u00f6nndahl","year":"2023","unstructured":"L\u00f6nndahl L et al (2023) Psychological stress and atopic dermatitis: A focus group study. Ann Dermatol 35:342\u2013347. https:\/\/doi.org\/10.5021\/ad.22.035","journal-title":"Ann Dermatol"},{"key":"9127_CR253","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/bjd.17605","volume":"181","author":"M Maarouf","year":"2019","unstructured":"Maarouf M, Maarouf CL, Yosipovitch G, Shi VY (2019) The impact of stress on epidermal barrier function: an evidence-based review. Br J Dermatol 181:1129\u20131137. https:\/\/doi.org\/10.1111\/bjd.17605","journal-title":"Br J Dermatol"},{"key":"9127_CR254","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1152\/physrev.2000.80.3.979","volume":"80","author":"A Slominski","year":"2000","unstructured":"Slominski A, Wortsman J, Luger T, Paus R, Solomon S (2000) Corticotropin releasing hormone and Proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 80:979\u20131020. https:\/\/doi.org\/10.1152\/physrev.2000.80.3.979","journal-title":"Physiol Rev"},{"key":"9127_CR255","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/edrv.21.5.0410","volume":"21","author":"A Slominski","year":"2000","unstructured":"Slominski A, Wortsman J (2000) Neuroendocrinology of the skin. Endocr Rev 21:457\u2013487. https:\/\/doi.org\/10.1210\/edrv.21.5.0410","journal-title":"Endocr Rev"},{"key":"9127_CR256","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18102131","author":"TK Lin","year":"2017","unstructured":"Lin TK, Zhong L, Santiago JL (2017) Association between stress and the HPA axis in the atopic dermatitis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms18102131","journal-title":"Int J Mol Sci"},{"key":"9127_CR257","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1038\/jid.2014.265","volume":"134","author":"TK Lin","year":"2014","unstructured":"Lin TK et al (2014) Paradoxical benefits of psychological stress in inflammatory dermatoses models are glucocorticoid mediated. J Invest Dermatol 134:2890\u20132897. https:\/\/doi.org\/10.1038\/jid.2014.265","journal-title":"J Invest Dermatol"},{"key":"9127_CR258","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/bjd.19115","volume":"184","author":"TW Fischer","year":"2021","unstructured":"Fischer TW et al (2021) New effects of caffeine on corticotropin-releasing hormone (CRH)-induced stress along the intrafollicular classical hypothalamic-pituitary-adrenal (HPA) axis (CRH-R1\/2, IP(3) -R, ACTH, MC-R2) and the neurogenic non-HPA axis (substance P, p75(NTR) and TrkA) in ex vivo human male androgenetic scalp hair follicles. Br J Dermatol 184:96\u2013110. https:\/\/doi.org\/10.1111\/bjd.19115","journal-title":"Br J Dermatol"},{"key":"9127_CR259","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/sj.jid.5701079","volume":"128","author":"S Pavlovic","year":"2008","unstructured":"Pavlovic S et al (2008) Further exploring the brain-skin connection: stress worsens dermatitis via substance P-dependent neurogenic inflammation in mice. J Invest Dermatol 128:434\u2013446. https:\/\/doi.org\/10.1038\/sj.jid.5701079","journal-title":"J Invest Dermatol"},{"key":"9127_CR260","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.jdermsci.2022.04.011","volume":"106","author":"M Chen","year":"2022","unstructured":"Chen M et al (2022) Keratinocytes take part in the regulation of substance P in melanogenesis through the HPA axis. J Dermatol Sci 106:141\u2013149. https:\/\/doi.org\/10.1016\/j.jdermsci.2022.04.011","journal-title":"J Dermatol Sci"},{"key":"9127_CR261","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3109\/10253890009001125","volume":"3","author":"DS Jessop","year":"2000","unstructured":"Jessop DS, Renshaw D, Larsen PJ, Chowdrey HS, Harbuz MS (2000) Substance P is involved in terminating the hypothalamo- pituitary-adrenal axis response to acute stress through centrally located neurokinin-1 receptors. Stress 3:209\u2013220. https:\/\/doi.org\/10.3109\/10253890009001125","journal-title":"Stress"},{"key":"9127_CR262","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/0889-1591(92)90044-o","volume":"6","author":"MS Harbuz","year":"1992","unstructured":"Harbuz MS, Stephanou A, Knight RA, Chover-Gonzalez AJ, Lightman SL (1992) Action of interleukin-2 and interleukin-4 on CRF mRNA in the hypothalamus and POMC mRNA in the anterior pituitary. Brain Behav Immun 6:214\u2013222. https:\/\/doi.org\/10.1016\/0889-1591(92)90044-o","journal-title":"Brain Behav Immun"},{"key":"9127_CR263","doi-asserted-by":"publisher","first-page":"14981","DOI":"10.1038\/s41598-018-33317-x","volume":"8","author":"G Park","year":"2018","unstructured":"Park G, Jung YS, Park MK, Yang CH, Kim YU (2018) Melatonin inhibits attention-deficit\/hyperactivity disorder caused by atopic dermatitis-induced psychological stress in an NC\/Nga atopic-like mouse model. Sci Rep 8:14981. https:\/\/doi.org\/10.1038\/s41598-018-33317-x","journal-title":"Sci Rep"},{"key":"9127_CR264","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121764","author":"M Sung","year":"2021","unstructured":"Sung M (2021) Serum-derived neuronal exosomal microRNAs as stress-related biomarkers in an atopic dermatitis model. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines9121764","journal-title":"Biomedicines"},{"key":"9127_CR265","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jdermsci.2010.03.020","volume":"58","author":"S Haas","year":"2010","unstructured":"Haas S et al (2010) Low density of sympathetic nerve fibers relative to substance P-positive nerve fibers in lesional skin of chronic pruritus and prurigo nodularis. J Dermatol Sci 58:193\u2013197. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.03.020","journal-title":"J Dermatol Sci"},{"key":"9127_CR266","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1365-2133.2008.08756.x","volume":"159","author":"D Cicek","year":"2008","unstructured":"Cicek D et al (2008) Does autonomic dysfunction play a role in atopic dermatitis? Br J Dermatol 159:834\u2013838. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08756.x","journal-title":"Br J Dermatol"},{"key":"9127_CR267","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/403908","volume":"2012","author":"JM Hall","year":"2012","unstructured":"Hall JM et al (2012) Psychological stress and the cutaneous immune response: roles of the HPA axis and the sympathetic nervous system in atopic dermatitis and psoriasis. Dermatol Res Pract 2012:403908. https:\/\/doi.org\/10.1155\/2012\/403908","journal-title":"Dermatol Res Pract"},{"key":"9127_CR268","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.neuropharm.2011.05.030","volume":"61","author":"Y Gotoh","year":"2011","unstructured":"Gotoh Y, Andoh T, Kuraishi Y (2011) Noradrenergic regulation of itch transmission in the spinal cord mediated by \u03b1-adrenoceptors. Neuropharmacology 61:825\u2013831. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.05.030","journal-title":"Neuropharmacology"},{"key":"9127_CR269","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1210\/jc.2001-010872","volume":"87","author":"A Buske-Kirschbaum","year":"2002","unstructured":"Buske-Kirschbaum A, Geiben A, H\u00f6llig H, Morschh\u00e4user E, Hellhammer D (2002) Altered responsiveness of the hypothalamus-pituitary-adrenal axis and the sympathetic adrenomedullary system to stress in patients with atopic dermatitis. J Clin Endocrinol Metab 87:4245\u20134251. https:\/\/doi.org\/10.1210\/jc.2001-010872","journal-title":"J Clin Endocrinol Metab"},{"key":"9127_CR270","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jaci.2024.10.038","volume":"155","author":"H Urakami","year":"2025","unstructured":"Urakami H et al (2025) Stress-experienced monocytes\/macrophages lose anti-inflammatory function via \u03b2(2)-adrenergic receptor in skin allergic inflammation. J Allergy Clin Immunol 155:865\u2013879. https:\/\/doi.org\/10.1016\/j.jaci.2024.10.038","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR271","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.4049\/jimmunol.171.8.4073","volume":"171","author":"P Saint-Mezard","year":"2003","unstructured":"Saint-Mezard P et al (2003) Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol 171:4073\u20134080. https:\/\/doi.org\/10.4049\/jimmunol.171.8.4073","journal-title":"J Immunol"},{"key":"9127_CR272","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1159\/000336498","volume":"98","author":"GD Scott","year":"2012","unstructured":"Scott GD, Fryer AD (2012) Role of parasympathetic nerves and muscarinic receptors in allergy and asthma. Chem Immunol Allergy 98:48\u201369. https:\/\/doi.org\/10.1159\/000336498","journal-title":"Chem Immunol Allergy"},{"key":"9127_CR273","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/jid.2011.264","volume":"132","author":"BJ Curtis","year":"2012","unstructured":"Curtis BJ, Radek KA (2012) Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and disease. J Invest Dermatol 132:28\u201342. https:\/\/doi.org\/10.1038\/jid.2011.264","journal-title":"J Invest Dermatol"},{"key":"9127_CR274","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3389\/fimmu.2017.01873","volume":"8","author":"G Bosmans","year":"2017","unstructured":"Bosmans G et al (2017) Cholinergic modulation of type 2 immune responses. Front Immunol 8:1873. https:\/\/doi.org\/10.3389\/fimmu.2017.01873","journal-title":"Front Immunol"},{"key":"9127_CR275","doi-asserted-by":"publisher","first-page":"e22029","DOI":"10.1371\/journal.pone.0022029","volume":"6","author":"EL Foster","year":"2011","unstructured":"Foster EL et al (2011) Eosinophils increase neuron branching in human and murine skin and in vitro. PLoS ONE 6:e22029. https:\/\/doi.org\/10.1371\/journal.pone.0022029","journal-title":"PLoS ONE"},{"key":"9127_CR276","doi-asserted-by":"publisher","first-page":"L1279","DOI":"10.1152\/ajplung.00279.2001","volume":"282","author":"DA Sawatzky","year":"2002","unstructured":"Sawatzky DA et al (2002) Eosinophil adhesion to cholinergic nerves via ICAM-1 and VCAM-1 and associated eosinophil degranulation. Am J Physiol Lung Cell Mol Physiol 282:L1279\u20131288. https:\/\/doi.org\/10.1152\/ajplung.00279.2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"9127_CR277","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1165\/rcmb.2005-0196OC","volume":"34","author":"N Durcan","year":"2006","unstructured":"Durcan N et al (2006) Eosinophil-mediated cholinergic nerve remodeling. Am J Respir Cell Mol Biol 34:775\u2013786. https:\/\/doi.org\/10.1165\/rcmb.2005-0196OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"9127_CR278","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.molimm.2014.05.014","volume":"62","author":"N Akasheh","year":"2014","unstructured":"Akasheh N, Walsh MT, Costello RW (2014) Eosinophil peroxidase induces expression of cholinergic genes via cell surface neural interactions. Mol Immunol 62:37\u201345. https:\/\/doi.org\/10.1016\/j.molimm.2014.05.014","journal-title":"Mol Immunol"},{"key":"9127_CR279","doi-asserted-by":"publisher","first-page":"859","DOI":"10.13201\/j.issn.2096-7993.2021.09.021","volume":"35","author":"S Cai","year":"2021","unstructured":"Cai S, Lou H (2021) [Neuroimmunomodulation in allergic rhinitis]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 35:859\u2013864. https:\/\/doi.org\/10.13201\/j.issn.2096-7993.2021.09.021","journal-title":"Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"9127_CR280","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","volume":"21","author":"CA Akdis","year":"2021","unstructured":"Akdis CA (2021) Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol 21:739\u2013751. https:\/\/doi.org\/10.1038\/s41577-021-00538-7","journal-title":"Nat Rev Immunol"},{"key":"9127_CR281","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23147735","author":"Z Fang","year":"2022","unstructured":"Fang Z (2022) Limosilactobacillus reuteri attenuates atopic dermatitis via changes in gut bacteria and indole derivatives from tryptophan metabolism. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23147735","journal-title":"Int J Mol Sci"},{"key":"9127_CR282","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113520","author":"K Kim","year":"2022","unstructured":"Kim K, Kim H, Sung GY (2022) Effects of indole-3-lactic acid, a metabolite of tryptophan, on IL-4 and IL-13-induced human skin-equivalent atopic dermatitis models. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232113520","journal-title":"Int J Mol Sci"},{"key":"9127_CR283","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2023.103096","volume":"141","author":"X Liu","year":"2023","unstructured":"Liu X et al (2023) Differential changes in the gut microbiota between extrinsic and intrinsic atopic dermatitis. J Autoimmun 141:103096. https:\/\/doi.org\/10.1016\/j.jaut.2023.103096","journal-title":"J Autoimmun"},{"key":"9127_CR284","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1021\/acs.jafc.3c06015","volume":"72","author":"D Li","year":"2024","unstructured":"Li D et al (2024) Ginsenoside F2-Mediated intestinal microbiota and its metabolite propionic acid positively impact the Gut-Skin axis in atopic dermatitis mice. J Agric Food Chem 72:339\u2013350. https:\/\/doi.org\/10.1021\/acs.jafc.3c06015","journal-title":"J Agric Food Chem"},{"key":"9127_CR285","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1111\/all.16065","volume":"79","author":"M Sasaki","year":"2024","unstructured":"Sasaki M et al (2024) Systematic review of the association between short-chain fatty acids and allergic diseases. Allergy 79:1789\u20131811. https:\/\/doi.org\/10.1111\/all.16065","journal-title":"Allergy"},{"key":"9127_CR286","doi-asserted-by":"publisher","first-page":"101017","DOI":"10.1016\/j.waojou.2024.101017","volume":"18","author":"B Du","year":"2025","unstructured":"Du B et al (2025) Gut microbiota and plasma metabolites in pregnant mothers and infant atopic dermatitis: A multi-omics study. World Allergy Organ J 18:101017. https:\/\/doi.org\/10.1016\/j.waojou.2024.101017","journal-title":"World Allergy Organ J"},{"key":"9127_CR287","doi-asserted-by":"publisher","first-page":"1442126","DOI":"10.3389\/fmicb.2024.1442126","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang X et al (2024) Changes in oral, skin, and gut microbiota in children with atopic dermatitis: a case-control study. Front Microbiol 15:1442126. https:\/\/doi.org\/10.3389\/fmicb.2024.1442126","journal-title":"Front Microbiol"},{"key":"9127_CR288","doi-asserted-by":"publisher","first-page":"e70031","DOI":"10.1111\/exd.70031","volume":"34","author":"T Zhang","year":"2025","unstructured":"Zhang T et al (2025) Pharyngeal Microbiome in atopic dermatitis: A 16S rRNA sequencing study. Exp Dermatol 34:e70031. https:\/\/doi.org\/10.1111\/exd.70031","journal-title":"Exp Dermatol"},{"key":"9127_CR289","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1038\/s41467-024-47072-3","volume":"15","author":"T Dokoshi","year":"2024","unstructured":"Dokoshi T et al (2024) Dermal injury drives a skin to gut axis that disrupts the intestinal Microbiome and intestinal immune homeostasis in mice. Nat Commun 15:3009. https:\/\/doi.org\/10.1038\/s41467-024-47072-3","journal-title":"Nat Commun"},{"key":"9127_CR290","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41598-018-23359-6","volume":"8","author":"SA Wazea","year":"2018","unstructured":"Wazea SA, Wadie W, Bahgat AK, El-Abhar HS (2018) Galantamine anti-colitic effect: role of alpha-7 nicotinic acetylcholine receptor in modulating Jak\/STAT3, NF-\u03baB\/HMGB1\/RAGE and p-AKT\/Bcl-2 pathways. Sci Rep 8:5110. https:\/\/doi.org\/10.1038\/s41598-018-23359-6","journal-title":"Sci Rep"},{"key":"9127_CR291","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz B, Bazin T, Pellissier S (2018) The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci 12:49. https:\/\/doi.org\/10.3389\/fnins.2018.00049","journal-title":"Front Neurosci"},{"key":"9127_CR292","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bbi.2015.07.009","volume":"50","author":"RM Stilling","year":"2015","unstructured":"Stilling RM et al (2015) Microbes & neurodevelopment\u2013absence of microbiota during early life increases activity-related transcriptional pathways in the amygdala. Brain Behav Immun 50:209\u2013220. https:\/\/doi.org\/10.1016\/j.bbi.2015.07.009","journal-title":"Brain Behav Immun"},{"key":"9127_CR293","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/1471-2180-14-189","volume":"14","author":"JD Galley","year":"2014","unstructured":"Galley JD et al (2014) Exposure to a social stressor disrupts the community structure of the colonic mucosa-associated microbiota. BMC Microbiol 14:189. https:\/\/doi.org\/10.1186\/1471-2180-14-189","journal-title":"BMC Microbiol"},{"key":"9127_CR294","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1189\/jlb.1109740","volume":"88","author":"KA Radek","year":"2010","unstructured":"Radek KA (2010) Antimicrobial anxiety: the impact of stress on antimicrobial immunity. J Leukoc Biol 88:263\u2013277. https:\/\/doi.org\/10.1189\/jlb.1109740","journal-title":"J Leukoc Biol"},{"key":"9127_CR295","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-56936-z","volume":"14","author":"DE Cho","year":"2024","unstructured":"Cho DE et al (2024) Role of gut-derived bacterial lipopolysaccharide and peripheral TLR4 in immobilization stress-induced itch aggravation in a mouse model of atopic dermatitis. Sci Rep 14:6263. https:\/\/doi.org\/10.1038\/s41598-024-56936-z","journal-title":"Sci Rep"},{"key":"9127_CR296","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.616489","volume":"8","author":"Y Li","year":"2021","unstructured":"Li Y et al (2021) The role of gut microbiota in chronic itch-evoked novel object recognition-related cognitive dysfunction in mice. Front Med 8:616489. https:\/\/doi.org\/10.3389\/fmed.2021.616489","journal-title":"Front Med"},{"key":"9127_CR297","doi-asserted-by":"publisher","unstructured":"Guideline for diagnosis And treatment of atopic dermatitis in China (2 020). Chin J Dermatol 53 https:\/\/doi.org\/10.35541\/cjd.20191000","DOI":"10.35541\/cjd.20191000"},{"key":"9127_CR298","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/bjd\/ljad032","volume":"188","author":"Y Wu","year":"2023","unstructured":"Wu Y et al (2023) Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab. Br J Dermatol 188:649\u2013660. https:\/\/doi.org\/10.1093\/bjd\/ljad032","journal-title":"Br J Dermatol"},{"key":"9127_CR299","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113383","volume":"143","author":"Y Yang","year":"2024","unstructured":"Yang Y et al (2024) Comparative effectiveness of upadacitinib versus dupilumab for moderate-to-severe atopic dermatitis: a retrospective cohort study. Int Immunopharmacol 143:113383. https:\/\/doi.org\/10.1016\/j.intimp.2024.113383","journal-title":"Int Immunopharmacol"},{"key":"9127_CR300","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00403-025-04090-5","volume":"317","author":"G Caiazzo","year":"2025","unstructured":"Caiazzo G et al (2025) Phenotype-endotype relationship in elderly atopic dermatitis and effects of dupilumab therapy: prospective study. Arch Dermatol Res 317:575. https:\/\/doi.org\/10.1007\/s00403-025-04090-5","journal-title":"Arch Dermatol Res"},{"key":"9127_CR301","doi-asserted-by":"publisher","first-page":"111867","DOI":"10.1016\/j.intimp.2024.111867","volume":"131","author":"L Yang","year":"2024","unstructured":"Yang L et al (2024) Dupilumab therapy improves gut Microbiome dysbiosis and Tryptophan metabolism in Chinese patients with atopic dermatitis. Int Immunopharmacol 131:111867. https:\/\/doi.org\/10.1016\/j.intimp.2024.111867","journal-title":"Int Immunopharmacol"},{"key":"9127_CR302","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2025.05.011","author":"MK Jha","year":"2025","unstructured":"Jha MK et al (2025) Type 2 cytokines pleiotropically modulate sensory nerve architecture and neuroimmune interactions to mediate itch. J Allergy Clin Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2025.05.011","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR303","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/09546634.2016.1174765","volume":"27","author":"JI Silverberg","year":"2016","unstructured":"Silverberg JI, Nelson DB, Yosipovitch G (2016) Addressing treatment challenges in atopic dermatitis with novel topical therapies. J Dermatolog Treat 27:568\u2013576. https:\/\/doi.org\/10.1080\/09546634.2016.1174765","journal-title":"J Dermatolog Treat"},{"key":"9127_CR304","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1001\/jamadermatol.2021.3023","volume":"157","author":"A Blauvelt","year":"2021","unstructured":"Blauvelt A et al (2021) Efficacy and safety of Upadacitinib vs dupilumab in adults with Moderate-to-Severe atopic dermatitis: A randomized clinical trial. JAMA Dermatol 157:1047\u20131055. https:\/\/doi.org\/10.1001\/jamadermatol.2021.3023","journal-title":"JAMA Dermatol"},{"key":"9127_CR305","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaci.2022.11.009","volume":"151","author":"T Hashimoto","year":"2023","unstructured":"Hashimoto T, Yokozeki H, Karasuyama H, Satoh T (2023) IL-31-generating network in atopic dermatitis comprising macrophages, basophils, thymic stromal lymphopoietin, and periostin. J Allergy Clin Immunol 151:737-746.e736. https:\/\/doi.org\/10.1016\/j.jaci.2022.11.009","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR306","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1111\/1346-8138.17171","volume":"51","author":"R Masuyuki","year":"2024","unstructured":"Masuyuki R, Sato E, Imafuku S (2024) A case of bullous pemphigoid following administration of anti-IL-31 receptor A antibody. J Dermatol 51:1252\u20131255. https:\/\/doi.org\/10.1111\/1346-8138.17171","journal-title":"J Dermatol"},{"key":"9127_CR307","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1111\/1346-8138.16428","volume":"49","author":"S Takamura","year":"2022","unstructured":"Takamura S, Teraki Y (2022) Treatment of bullous pemphigoid with dupilumab: dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines. J Dermatol 49:845\u2013850. https:\/\/doi.org\/10.1111\/1346-8138.16428","journal-title":"J Dermatol"},{"key":"9127_CR308","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/aln.0000000000005354","volume":"142","author":"Q Zhang","year":"2025","unstructured":"Zhang Q et al (2025) Pyridoxine prevents postoperative nausea and vomiting in gynecologic laparoscopic surgery: A Double-blind randomized controlled trial. Anesthesiology 142:655\u2013665. https:\/\/doi.org\/10.1097\/aln.0000000000005354","journal-title":"Anesthesiology"},{"key":"9127_CR309","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s1474-4422(22)00517-8","volume":"22","author":"RB Lipton","year":"2023","unstructured":"Lipton RB et al (2023) Safety, tolerability, and efficacy of Zavegepant 10\u00a0mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial. Lancet Neurol 22:209\u2013217. https:\/\/doi.org\/10.1016\/s1474-4422(22)00517-8","journal-title":"Lancet Neurol"},{"key":"9127_CR310","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2340\/00015555-2852","volume":"98","author":"L L\u00f6nndahl","year":"2018","unstructured":"L\u00f6nndahl L et al (2018) Substance P antagonist aprepitant shows no additive effect compared with standardized topical treatment alone in patients with atopic dermatitis. Acta Derm Venereol 98:324\u2013328. https:\/\/doi.org\/10.2340\/00015555-2852","journal-title":"Acta Derm Venereol"},{"key":"9127_CR311","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2340\/00015555-2780","volume":"98","author":"T Ohanyan","year":"2018","unstructured":"Ohanyan T et al (2018) Role of substance P and its receptor neurokinin 1 in chronic prurigo: a randomized, proof-of-concept, controlled trial with topical aprepitant. Acta Derm Venereol 98:26\u201331. https:\/\/doi.org\/10.2340\/00015555-2780","journal-title":"Acta Derm Venereol"},{"key":"9127_CR312","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2340\/0001555571291295","volume":"71","author":"G Heyer","year":"1991","unstructured":"Heyer G, Hornstein OP, Handwerker HO (1991) Reactions to intradermally injected substance P and topically applied mustard oil in atopic dermatitis patients. Acta Derm Venereol 71:291\u2013295","journal-title":"Acta Derm Venereol"},{"key":"9127_CR313","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1113\/jphysiol.2005.095372","volume":"568","author":"BJ Wong","year":"2005","unstructured":"Wong BJ, Tublitz NJ, Minson CT (2005) Neurokinin-1 receptor desensitization to consecutive microdialysis infusions of substance P in human skin. J Physiol 568:1047\u20131056. https:\/\/doi.org\/10.1113\/jphysiol.2005.095372","journal-title":"J Physiol"},{"key":"9127_CR314","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/1523-1747.ep12455620","volume":"87","author":"SD Brain","year":"1986","unstructured":"Brain SD, Tippins JR, Morris HR, MacIntyre I, Williams TJ (1986) Potent vasodilator activity of calcitonin gene-related peptide in human skin. J Invest Dermatol 87:533\u2013536. https:\/\/doi.org\/10.1111\/1523-1747.ep12455620","journal-title":"J Invest Dermatol"},{"key":"9127_CR315","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1124\/jpet.107.133868","volume":"325","author":"BJ Van der Schueren","year":"2008","unstructured":"Van der Schueren BJ et al (2008) Calcitonin gene-related peptide8-37 antagonizes capsaicin-induced vasodilation in the skin: evaluation of a human in vivo pharmacodynamic model. J Pharmacol Exp Ther 325:248\u2013255. https:\/\/doi.org\/10.1124\/jpet.107.133868","journal-title":"J Pharmacol Exp Ther"},{"key":"9127_CR316","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s11095-017-2183-6","volume":"34","author":"T Vu","year":"2017","unstructured":"Vu T et al (2017) Pharmacokinetic-Pharmacodynamic relationship of erenumab (AMG 334) and Capsaicin-Induced dermal blood flow in healthy and migraine subjects. Pharm Res 34:1784\u20131795. https:\/\/doi.org\/10.1007\/s11095-017-2183-6","journal-title":"Pharm Res"},{"key":"9127_CR317","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/cpt.1401","volume":"106","author":"JR Parnes","year":"2019","unstructured":"Parnes JR, Sullivan JT, Chen L, Dias C (2019) Pharmacokinetics, safety, and tolerability of tezepelumab (AMG 157) in healthy and atopic dermatitis adult subjects. Clin Pharmacol Ther 106:441\u2013449. https:\/\/doi.org\/10.1002\/cpt.1401","journal-title":"Clin Pharmacol Ther"},{"key":"9127_CR318","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.jaad.2018.11.059","volume":"80","author":"EL Simpson","year":"2019","unstructured":"Simpson EL et al (2019) Tezepelumab, an anti-thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial. J Am Acad Dermatol 80:1013\u20131021. https:\/\/doi.org\/10.1016\/j.jaad.2018.11.059","journal-title":"J Am Acad Dermatol"},{"key":"9127_CR319","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/13543784.2024.2305144","volume":"33","author":"P Rogliani","year":"2024","unstructured":"Rogliani P, Manzetti GM, Bettin FR, D\u2019Auria M, Calzetta L (2024) Investigational thymic stromal lymphopoietin inhibitors for the treatment of asthma: a systematic review. Expert Opin Investig Drugs 33:39\u201349. https:\/\/doi.org\/10.1080\/13543784.2024.2305144","journal-title":"Expert Opin Investig Drugs"},{"key":"9127_CR320","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2945","author":"YL Chen","year":"2019","unstructured":"Chen YL (2019) Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aax2945","journal-title":"Sci Transl Med"},{"key":"9127_CR321","doi-asserted-by":"publisher","first-page":"e13874","DOI":"10.1111\/cts.13874","volume":"17","author":"MP Kosloski","year":"2024","unstructured":"Kosloski MP et al (2024) Pharmacokinetics and pharmacodynamics of Itepekimab in adults with moderate-to-severe atopic dermatitis: results from two terminated phase II trials. Clin Transl Sci 17:e13874. https:\/\/doi.org\/10.1111\/cts.13874","journal-title":"Clin Transl Sci"},{"key":"9127_CR322","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/bjd.21631","volume":"187","author":"V Laquer","year":"2022","unstructured":"Laquer V et al (2022) Interleukin-33 antibody failed to demonstrate benefit in a phase II, double-blind, randomized, placebo-controlled study in adult patients with moderate-to-severe atopic dermatitis. Br J Dermatol 187:599\u2013602. https:\/\/doi.org\/10.1111\/bjd.21631","journal-title":"Br J Dermatol"},{"key":"9127_CR323","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/j.jaci.2022.08.015","volume":"150","author":"M Maurer","year":"2022","unstructured":"Maurer M et al (2022) Phase 2 randomized clinical trial of Astegolimab in patients with moderate to severe atopic dermatitis. J Allergy Clin Immunol 150:1517\u20131524. https:\/\/doi.org\/10.1016\/j.jaci.2022.08.015","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR324","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/13543784.2025.2453162","volume":"34","author":"H Zhang","year":"2025","unstructured":"Zhang H et al (2025) First-in-human study on tolerability, pharmacokinetics and pharmacodynamics of single and multiple escalating doses of XKH001, a recombinant humanized monoclonal antibody against IL-25 in healthy Chinese volunteers. Expert Opin Investig Drugs 34:81\u201387. https:\/\/doi.org\/10.1080\/13543784.2025.2453162","journal-title":"Expert Opin Investig Drugs"},{"key":"9127_CR325","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1495540","volume":"15","author":"G Xu","year":"2024","unstructured":"Xu G et al (2024) Evaluation of the safety, tolerability, pharmacokinetics and pharmacodynamics of SM17 in healthy volunteers: results from pre-clinical models and a first-in-human, randomized, double blinded clinical trial. Front Immunol 15:1495540. https:\/\/doi.org\/10.3389\/fimmu.2024.1495540","journal-title":"Front Immunol"},{"key":"9127_CR326","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jdv.18727","volume":"37","author":"R Bissonnette","year":"2023","unstructured":"Bissonnette R et al (2023) Spesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: results from a multicentre, randomized, double-blind, placebo-controlled, phase IIa study. J Eur Acad Dermatol Venereol 37:549\u2013557. https:\/\/doi.org\/10.1111\/jdv.18727","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"9127_CR327","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jaci.2021.08.009","volume":"148","author":"R Chovatiya","year":"2021","unstructured":"Chovatiya R, Paller AS (2021) JAK inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol 148:927\u2013940. https:\/\/doi.org\/10.1016\/j.jaci.2021.08.009","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR328","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.jaad.2021.04.085","volume":"85","author":"K Papp","year":"2021","unstructured":"Papp K et al (2021) Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: results from 2 phase 3, randomized, double-blind studies. J Am Acad Dermatol 85:863\u2013872. https:\/\/doi.org\/10.1016\/j.jaad.2021.04.085","journal-title":"J Am Acad Dermatol"},{"key":"9127_CR329","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s40257-024-00855-2","volume":"25","author":"LF Eichenfield","year":"2024","unstructured":"Eichenfield LF et al (2024) Efficacy, Safety, and Long-Term disease control of ruxolitinib cream among adolescents with atopic dermatitis: pooled results from two randomized phase 3 studies. Am J Clin Dermatol 25:669\u2013683. https:\/\/doi.org\/10.1007\/s40257-024-00855-2","journal-title":"Am J Clin Dermatol"},{"key":"9127_CR330","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jaad.2019.12.015","volume":"82","author":"H Nakagawa","year":"2020","unstructured":"Nakagawa H et al (2020) Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study. J Am Acad Dermatol 82:823\u2013831. https:\/\/doi.org\/10.1016\/j.jaad.2019.12.015","journal-title":"J Am Acad Dermatol"},{"key":"9127_CR331","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002735","author":"GR Burmester","year":"2023","unstructured":"Burmester GR (2023) Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis. RMD Open. https:\/\/doi.org\/10.1136\/rmdopen-2022-002735","journal-title":"RMD Open"},{"key":"9127_CR332","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s13555-023-00892-5","volume":"13","author":"C Samuel","year":"2023","unstructured":"Samuel C, Cornman H, Kambala A, Kwatra SG (2023) A review on the safety of using JAK inhibitors in dermatology: clinical and laboratory monitoring. Dermatol Ther (Heidelb) 13:729\u2013749. https:\/\/doi.org\/10.1007\/s13555-023-00892-5","journal-title":"Dermatol Ther (Heidelb)"},{"key":"9127_CR333","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/derm.2023.0132","volume":"35","author":"D Huang","year":"2024","unstructured":"Huang D, Lu J, Tan F (2024) Improvement of pruritus and efficacy in the early stage of therapy with Upadacitinib, Abrocitinib, or dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: prospective, cohort, observational study. Dermatitis 35:77\u201383. https:\/\/doi.org\/10.1089\/derm.2023.0132","journal-title":"Dermatitis"},{"key":"9127_CR334","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/s0140-6736(22)01199-0","volume":"400","author":"K Reich","year":"2022","unstructured":"Reich K et al (2022) Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial. Lancet 400:273\u2013282. https:\/\/doi.org\/10.1016\/s0140-6736(22)01199-0","journal-title":"Lancet"},{"key":"9127_CR335","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1056\/NEJMoa2019380","volume":"384","author":"T Bieber","year":"2021","unstructured":"Bieber T et al (2021) Abrocitinib versus placebo or dupilumab for atopic dermatitis. N Engl J Med 384:1101\u20131112. https:\/\/doi.org\/10.1056\/NEJMoa2019380","journal-title":"N Engl J Med"},{"key":"9127_CR336","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/bjd\/ljae404","volume":"192","author":"JI Silverberg","year":"2024","unstructured":"Silverberg JI et al (2024) Efficacy and safety of upadacitinib versus dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis: week 16 results of an open-label randomized efficacy assessor-blinded head-to-head phase IIIb\/IV study (Level Up). Br J Dermatol 192:36\u201345. https:\/\/doi.org\/10.1093\/bjd\/ljae404","journal-title":"Br J Dermatol"},{"key":"9127_CR337","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/bjd\/ljad096","volume":"189","author":"A Torrelo","year":"2023","unstructured":"Torrelo A et al (2023) Efficacy and safety of baricitinib in combination with topical corticosteroids in paediatric patients with moderate-to-severe atopic dermatitis with an inadequate response to topical corticosteroids: results from a phase III, randomized, double-blind, placebo-controlled study (BREEZE-AD PEDS). Br J Dermatol 189:23\u201332. https:\/\/doi.org\/10.1093\/bjd\/ljad096","journal-title":"Br J Dermatol"},{"key":"9127_CR338","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/bjd.17455","volume":"180","author":"YW Lee","year":"2019","unstructured":"Lee YW et al (2019) Efficacy and safety of PAC-14028 cream - a novel, topical, nonsteroidal, selective TRPV1 antagonist in patients with mild-to-moderate atopic dermatitis: a phase IIb randomized trial. Br J Dermatol 180:1030\u20131038. https:\/\/doi.org\/10.1111\/bjd.17455","journal-title":"Br J Dermatol"},{"key":"9127_CR339","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1021\/acs.jmedchem.8b00109","volume":"61","author":"M Serafini","year":"2018","unstructured":"Serafini M et al (2018) Targeting Transient Receptor Potential Vanilloid 1 (TRPV1) channel softly: the discovery of Passerini adducts as a topical treatment for inflammatory skin disorders. J Med Chem 61:4436\u20134455. https:\/\/doi.org\/10.1021\/acs.jmedchem.8b00109","journal-title":"J Med Chem"},{"key":"9127_CR340","doi-asserted-by":"publisher","first-page":"881","DOI":"10.2147\/jir.S425978","volume":"17","author":"NK Kordulewska","year":"2024","unstructured":"Kordulewska NK, Kr\u00f3l-Grzyma\u0142a A (2024) The effect of osthole on transient receptor potential channels: a possible alternative therapy for atopic dermatitis. J Inflamm Res 17:881\u2013898. https:\/\/doi.org\/10.2147\/jir.S425978","journal-title":"J Inflamm Res"},{"key":"9127_CR341","doi-asserted-by":"publisher","first-page":"608","DOI":"10.21037\/atm-22-2101","volume":"10","author":"X Wang","year":"2022","unstructured":"Wang X et al (2022) Study on the intervention effect and mechanism of Bacillus Calmette-Guerin polysaccharide and nucleic acid injection on atopic dermatitis by targeting the transient receptor potential vanilloid subtype 1 pathway. Ann Transl Med 10:608. https:\/\/doi.org\/10.21037\/atm-22-2101","journal-title":"Ann Transl Med"},{"key":"9127_CR342","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/cts.13215","volume":"15","author":"HJ Hijma","year":"2022","unstructured":"Hijma HJ, van Brummelen EMJ, Siebenga PS, Groeneveld GJ (2022) A phase I, randomized, double-blind, placebo-controlled, single- and multiple dose escalation study evaluating the safety, pharmacokinetics and pharmacodynamics of VX-128, a highly selective Na(v) 1.8 inhibitor, in healthy adults. Clin Transl Sci 15:981\u2013993. https:\/\/doi.org\/10.1111\/cts.13215","journal-title":"Clin Transl Sci"},{"key":"9127_CR343","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1038\/s41598-020-59092-2","volume":"10","author":"H K\u00fchn","year":"2020","unstructured":"K\u00fchn H et al (2020) Complementary roles of murine Na(V)1.7, Na(V)1.8 and Na(V)1.9 in acute itch signalling. Sci Rep 10:2326. https:\/\/doi.org\/10.1038\/s41598-020-59092-2","journal-title":"Sci Rep"},{"key":"9127_CR344","doi-asserted-by":"publisher","first-page":"e0237101","DOI":"10.1371\/journal.pone.0237101","volume":"15","author":"M Ebbinghaus","year":"2020","unstructured":"Ebbinghaus M et al (2020) Gain-of-function mutation in SCN11A causes itch and affects neurogenic inflammation and muscle function in Scn11a+\/L799P mice. PLoS ONE 15:e0237101. https:\/\/doi.org\/10.1371\/journal.pone.0237101","journal-title":"PLoS ONE"},{"key":"9127_CR345","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1021\/acschemneuro.2c00012","volume":"13","author":"S Li","year":"2022","unstructured":"Li S et al (2022) Histamine sensitization of the Voltage-Gated sodium channel Nav1.7 contributes to histaminergic itch in mice. ACS Chem Neurosci 13:700\u2013710. https:\/\/doi.org\/10.1021\/acschemneuro.2c00012","journal-title":"ACS Chem Neurosci"},{"key":"9127_CR346","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.pain.2014.05.006","volume":"155","author":"G Devigili","year":"2014","unstructured":"Devigili G et al (2014) Paroxysmal itch caused by gain-of-function Nav1.7 mutation. Pain 155:1702\u20131707. https:\/\/doi.org\/10.1016\/j.pain.2014.05.006","journal-title":"Pain"},{"key":"9127_CR347","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1172\/jci122481","volume":"128","author":"J Salvatierra","year":"2018","unstructured":"Salvatierra J et al (2018) A disease mutation reveals a role for NaV1.9 in acute itch. J Clin Invest 128:5434\u20135447. https:\/\/doi.org\/10.1172\/jci122481","journal-title":"J Clin Invest"},{"key":"9127_CR348","doi-asserted-by":"publisher","first-page":"e70564","DOI":"10.1096\/fj.202402876R","volume":"39","author":"H Taira","year":"2025","unstructured":"Taira H et al (2025) EGF-Induced macropinocytosis promotes NAV1-Dependent internalization of occludin in keratinocytes. Faseb J 39:e70564. https:\/\/doi.org\/10.1096\/fj.202402876R","journal-title":"Faseb J"},{"key":"9127_CR349","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature13199","volume":"510","author":"L Riol-Blanco","year":"2014","unstructured":"Riol-Blanco L et al (2014) Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation. Nature 510:157\u2013161. https:\/\/doi.org\/10.1038\/nature13199","journal-title":"Nature"},{"key":"9127_CR350","doi-asserted-by":"publisher","first-page":"102427","DOI":"10.1016\/j.redox.2022.102427","volume":"55","author":"Y Zhang","year":"2022","unstructured":"Zhang Y et al (2022) Nav1.8 in keratinocytes contributes to ROS-mediated inflammation in inflammatory skin diseases. Redox Biol 55:102427. https:\/\/doi.org\/10.1016\/j.redox.2022.102427","journal-title":"Redox Biol"},{"key":"9127_CR351","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/j.pain.0000000000000723","volume":"158","author":"T Hoffmann","year":"2017","unstructured":"Hoffmann T et al (2017) Reduced excitability and impaired nociception in peripheral unmyelinated fibers from Nav1.9-null mice. Pain 158:58\u201367. https:\/\/doi.org\/10.1097\/j.pain.0000000000000723","journal-title":"Pain"},{"key":"9127_CR352","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/aln.0000000000003427","volume":"133","author":"S Chandra","year":"2020","unstructured":"Chandra S et al (2020) Computer-aided discovery of a new Nav1.7 inhibitor for treatment of pain and itch. Anesthesiology 133:611\u2013627. https:\/\/doi.org\/10.1097\/aln.0000000000003427","journal-title":"Anesthesiology"},{"key":"9127_CR353","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236058","author":"F Zhang","year":"2019","unstructured":"Zhang F (2019) 3\u2019-O-methylorobol inhibits the voltage-gated sodium channel Nav1.7 with anti-itch efficacy in a histamine-dependent itch mouse model. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20236058","journal-title":"Int J Mol Sci"},{"key":"9127_CR354","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.jaad.2024.05.023","volume":"91","author":"JI Silverberg","year":"2024","unstructured":"Silverberg JI et al (2024) Tapinarof cream 1% once daily: significant efficacy in the treatment of moderate to severe atopic dermatitis in adults and children down to 2 years of age in the pivotal phase 3 adoring trials. J Am Acad Dermatol 91:457\u2013465. https:\/\/doi.org\/10.1016\/j.jaad.2024.05.023","journal-title":"J Am Acad Dermatol"},{"key":"9127_CR355","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jaad.2020.05.135","volume":"84","author":"AS Paller","year":"2021","unstructured":"Paller AS et al (2021) Efficacy and patient-reported outcomes from a phase 2b, randomized clinical trial of tapinarof cream for the treatment of adolescents and adults with atopic dermatitis. J Am Acad Dermatol 84:632\u2013638. https:\/\/doi.org\/10.1016\/j.jaad.2020.05.135","journal-title":"J Am Acad Dermatol"},{"key":"9127_CR356","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2444489","volume":"36","author":"LS Gold","year":"2025","unstructured":"Gold LS et al (2025) Tapinarof cream 1% once daily was well tolerated in adults and children with atopic dermatitis in two phase 3 randomized trials. J Dermatolog Treat 36:2444489. https:\/\/doi.org\/10.1080\/09546634.2024.2444489","journal-title":"J Dermatolog Treat"},{"key":"9127_CR357","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13060732","author":"G Tsuji","year":"2024","unstructured":"Tsuji G, Yumine A, Kawamura K, Takemura M, Nakahara T (2024) Induction of semaphorin 3A by resveratrol and pinostilbene via activation of the AHR-NRF2 axis in human keratinocytes. Antioxidants. https:\/\/doi.org\/10.3390\/antiox13060732","journal-title":"Antioxidants"},{"key":"9127_CR358","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.3892\/mmr.2019.10405","volume":"20","author":"W Wu","year":"2019","unstructured":"Wu W et al (2019) Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2\/HO\u20131 axis. Mol Med Rep 20:1761\u20131771. https:\/\/doi.org\/10.3892\/mmr.2019.10405","journal-title":"Mol Med Rep"},{"key":"9127_CR359","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2044723","volume":"14","author":"Z Fang","year":"2022","unstructured":"Fang Z et al (2022) Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis. Gut Microbes 14:2044723. https:\/\/doi.org\/10.1080\/19490976.2022.2044723","journal-title":"Gut Microbes"},{"key":"9127_CR360","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1275427","volume":"14","author":"WY Deng","year":"2023","unstructured":"Deng WY, Chen WJ, Zhong HJ, Wu LH, He XX (2023) Washed microbiota transplantation: a case report of clinical success with skin and gut microbiota improvement in an adolescent boy with atopic dermatitis. Front Immunol 14:1275427. https:\/\/doi.org\/10.3389\/fimmu.2023.1275427","journal-title":"Front Immunol"},{"key":"9127_CR361","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2018.08.005","volume":"142","author":"YS Chang","year":"2018","unstructured":"Chang YS, Chiang BL (2018) Sleep disorders and atopic dermatitis: a 2-way street? J Allergy Clin Immunol 142:1033\u20131040. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.005","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR362","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081179","author":"AK Jaworek","year":"2021","unstructured":"Jaworek AK, Szepietowski JC, Ha\u0142ubiec P, Wojas-Pelc A, Jaworek J (2021) Melatonin as an antioxidant and immunomodulator in atopic dermatitis-a new look on an old story: a review. Antioxidants. https:\/\/doi.org\/10.3390\/antiox10081179","journal-title":"Antioxidants"},{"key":"9127_CR363","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031373","author":"YS Chang","year":"2022","unstructured":"Chang YS, Tsai CC, Yang PY, Tang CY, Chiang BL (2022) Topical melatonin exerts immunomodulatory effect and improves dermatitis severity in a mouse model of atopic dermatitis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031373","journal-title":"Int J Mol Sci"},{"key":"9127_CR364","doi-asserted-by":"publisher","unstructured":"Yang L et al (2025) Melatonin treatment increases skin microbiota-derived propionic acid to alleviate atopic dermatitis. J Allergy Clin Immunol 155, 880\u2013891.e889 https:\/\/doi.org\/10.1016\/j.jaci.2024.11.019","DOI":"10.1016\/j.jaci.2024.11.019"},{"key":"9127_CR365","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jamapediatrics.2015.3092","volume":"170","author":"YS Chang","year":"2016","unstructured":"Chang YS et al (2016) Melatonin supplementation for children with atopic dermatitis and sleep disturbance: A randomized clinical trial. JAMA Pediatr 170:35\u201342. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.3092","journal-title":"JAMA Pediatr"},{"key":"9127_CR366","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/pai.12978","volume":"29","author":"A Taghavi Ardakani","year":"2018","unstructured":"Taghavi Ardakani A et al (2018) The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double-blinded, placebo-controlled trial. Pediatr Allergy Immunol 29:834\u2013840. https:\/\/doi.org\/10.1111\/pai.12978","journal-title":"Pediatr Allergy Immunol"},{"key":"9127_CR367","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1111\/bph.16334","volume":"181","author":"C S\u00e9voz-Couche","year":"2024","unstructured":"S\u00e9voz-Couche C et al (2024) Direct vagus nerve stimulation: a new tool to control allergic airway inflammation through \u03b17 nicotinic acetylcholine receptor. Br J Pharmacol 181:1916\u20131934. https:\/\/doi.org\/10.1111\/bph.16334","journal-title":"Br J Pharmacol"},{"key":"9127_CR368","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25084196","author":"E Kavakbasi","year":"2024","unstructured":"Kavakbasi E, Van Assche E, Schwarte K, Hohoff C, Baune BT (2024) Long-term immunomodulatory impact of VNS on peripheral cytokine profiles and its relationship with clinical response in difficult-to-treat depression (DTD). Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25084196","journal-title":"Int J Mol Sci"},{"key":"9127_CR369","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1212\/wnl.59.1.108","volume":"59","author":"A Kirchner","year":"2002","unstructured":"Kirchner A, Stefan H, Schmelz M, Haslbeck KM, Birklein F (2002) Influence of vagus nerve stimulation on histamine-induced itching. Neurology 59:108\u2013112. https:\/\/doi.org\/10.1212\/wnl.59.1.108","journal-title":"Neurology"},{"key":"9127_CR370","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/dth.12242","volume":"28","author":"BM Mohammad Ali","year":"2015","unstructured":"Mohammad Ali BM, Hegab DS, El Saadany HM (2015) Use of transcutaneous electrical nerve stimulation for chronic pruritus. Dermatol Ther 28:210\u2013215. https:\/\/doi.org\/10.1111\/dth.12242","journal-title":"Dermatol Ther"},{"key":"9127_CR371","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1080\/09546634.2019.1657227","volume":"31","author":"MJ Visconti","year":"2020","unstructured":"Visconti MJ, Haidari W, Feldman SR (2020) Transcutaneous electrical nerve stimulation (TENS): a review of applications in dermatology. J Dermatolog Treat 31:846\u2013849. https:\/\/doi.org\/10.1080\/09546634.2019.1657227","journal-title":"J Dermatolog Treat"},{"key":"9127_CR372","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/AJP.0b013e31826b1329","volume":"29","author":"H Knotkova","year":"2013","unstructured":"Knotkova H, Portenoy RK, Cruciani RA (2013) Transcranial direct current stimulation (tDCS) relieved itching in a patient with chronic neuropathic pain. Clin J Pain 29:621\u2013622. https:\/\/doi.org\/10.1097\/AJP.0b013e31826b1329","journal-title":"Clin J Pain"},{"key":"9127_CR373","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1111\/exd.13803","volume":"28","author":"O Jones","year":"2019","unstructured":"Jones O, Schindler I, Holle H (2019) Transcranial magnetic stimulation over contralateral primary somatosensory cortex disrupts perception of itch intensity. Exp Dermatol 28:1380\u20131384. https:\/\/doi.org\/10.1111\/exd.13803","journal-title":"Exp Dermatol"},{"key":"9127_CR374","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-69973-5","volume":"14","author":"JJ Kim","year":"2024","unstructured":"Kim JJ, Day MA (2024) The neuroscience of itch in relation to transdiagnostic psychological approaches. Sci Rep 14:21476. https:\/\/doi.org\/10.1038\/s41598-024-69973-5","journal-title":"Sci Rep"},{"key":"9127_CR375","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/16506073.2018.1504320","volume":"48","author":"E Hedman-Lagerl\u00f6f","year":"2019","unstructured":"Hedman-Lagerl\u00f6f E, Bergman A, Lindefors N, Bradley M (2019) Exposure-based cognitive behavior therapy for atopic dermatitis: an open trial. Cogn Behav Ther 48:300\u2013310. https:\/\/doi.org\/10.1080\/16506073.2018.1504320","journal-title":"Cogn Behav Ther"},{"key":"9127_CR376","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1001\/jamadermatol.2021.1450","volume":"157","author":"E Hedman-Lagerl\u00f6f","year":"2021","unstructured":"Hedman-Lagerl\u00f6f E et al (2021) Internet-Delivered cognitive behavior therapy for atopic dermatitis: A randomized clinical trial. JAMA Dermatol 157:796\u2013804. https:\/\/doi.org\/10.1001\/jamadermatol.2021.1450","journal-title":"JAMA Dermatol"},{"key":"9127_CR377","doi-asserted-by":"publisher","DOI":"10.12932\/ap-100223-1542","author":"W Zhai","year":"2023","unstructured":"Zhai W et al (2023) Efficacy and associated neurotransmitters of digital cognitive behavior therapy for atopic dermatitis: A comparative effectiveness research. Asian Pac J Allergy Immunol. https:\/\/doi.org\/10.12932\/ap-100223-1542","journal-title":"Asian Pac J Allergy Immunol"},{"key":"9127_CR378","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00421-007-0469-9","volume":"100","author":"T Bender","year":"2007","unstructured":"Bender T et al (2007) The effect of physical therapy on beta-endorphin levels. Eur J Appl Physiol 100:371\u2013382. https:\/\/doi.org\/10.1007\/s00421-007-0469-9","journal-title":"Eur J Appl Physiol"},{"key":"9127_CR379","doi-asserted-by":"publisher","first-page":"111207","DOI":"10.1016\/j.brainresbull.2025.111207","volume":"221","author":"Y Chen","year":"2025","unstructured":"Chen Y et al (2025) Electroacupuncture and Tongbian Decoction ameliorate CUMS-induced depression and constipation in mice via TPH2\/5-HT pathway of the gut-brain axis. Brain Res Bull 221:111207. https:\/\/doi.org\/10.1016\/j.brainresbull.2025.111207","journal-title":"Brain Res Bull"},{"key":"9127_CR380","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","volume":"375","author":"EL Simpson","year":"2016","unstructured":"Simpson EL et al (2016) Two phase 3 trials of dupilumab versus placebo in atopic dermatitis. N Engl J Med 375:2335\u20132348. https:\/\/doi.org\/10.1056\/NEJMoa1610020","journal-title":"N Engl J Med"},{"key":"9127_CR381","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1130933","volume":"14","author":"PM Topczewska","year":"2023","unstructured":"Topczewska PM et al (2023) ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses. Front Immunol 14:1130933. https:\/\/doi.org\/10.3389\/fimmu.2023.1130933","journal-title":"Front Immunol"},{"key":"9127_CR382","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00826","volume":"10","author":"GJM Cameron","year":"2019","unstructured":"Cameron GJM et al (2019) Group 2 innate lymphoid cells are redundant in experimental renal ischemia-reperfusion injury. Front Immunol 10:826. https:\/\/doi.org\/10.3389\/fimmu.2019.00826","journal-title":"Front Immunol"},{"key":"9127_CR383","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jaci.2021.03.044","volume":"148","author":"SG Kelsen","year":"2021","unstructured":"Kelsen SG et al (2021) Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial. J Allergy Clin Immunol 148:790\u2013798. https:\/\/doi.org\/10.1016\/j.jaci.2021.03.044","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR384","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/ijd.12992","volume":"55","author":"J Bogaczewicz","year":"2016","unstructured":"Bogaczewicz J, Malinowska K, Sysa-Jedrzejowska A, Wozniacka A (2016) Medium-dose ultraviolet A1 phototherapy and mRNA expression of TSLP, TARC, IL-5, and IL-13 in acute skin lesions in atopic dermatitis. Int J Dermatol 55:856\u2013863. https:\/\/doi.org\/10.1111\/ijd.12992","journal-title":"Int J Dermatol"},{"key":"9127_CR385","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1342176","volume":"11","author":"Y Yamamura","year":"2024","unstructured":"Yamamura Y, Nakashima C, Otsuka A (2024) Interplay of cytokines in the pathophysiology of atopic dermatitis: insights from Murin models and human. Front Med Lausanne 11:1342176. https:\/\/doi.org\/10.3389\/fmed.2024.1342176","journal-title":"Front Med Lausanne"},{"key":"9127_CR386","doi-asserted-by":"publisher","first-page":"S65","DOI":"10.1016\/j.jaci.2017.01.011","volume":"139","author":"PM Brunner","year":"2017","unstructured":"Brunner PM, Guttman-Yassky E, Leung DY (2017) The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol 139:S65\u2013s76. https:\/\/doi.org\/10.1016\/j.jaci.2017.01.011","journal-title":"J Allergy Clin Immunol"},{"key":"9127_CR387","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2332\/allergolint.11-RAI-0394","volume":"61","author":"S Hanabuchi","year":"2012","unstructured":"Hanabuchi S, Watanabe N, Liu YJ (2012) Tslp and immune homeostasis. Allergol Int 61:19\u201325. https:\/\/doi.org\/10.2332\/allergolint.11-RAI-0394","journal-title":"Allergol Int"},{"key":"9127_CR388","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12016-015-8498-3","volume":"50","author":"GJ Webb","year":"2016","unstructured":"Webb GJ, Hirschfield GM, Lane PJ (2016) OX40, OX40L and Autoimmunity: a Comprehensive Review. Clin Rev Allergy Immunol 50:312\u2013332. https:\/\/doi.org\/10.1007\/s12016-015-8498-3","journal-title":"Clin Rev Allergy Immunol"},{"key":"9127_CR389","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41580-024-00768-2","volume":"26","author":"GS Gulati","year":"2025","unstructured":"Gulati GS, D\u2019Silva JP, Liu Y, Wang L, Newman AM (2025) Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics. Nat Rev Mol Cell Biol 26:11\u201331. https:\/\/doi.org\/10.1038\/s41580-024-00768-2","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9127_CR390","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1007\/s00467-011-1818-9","volume":"26","author":"DJ Christensen","year":"2011","unstructured":"Christensen DJ, Nedergaard M (2011) Two-photon in vivo imaging of cells. Pediatr Nephrol 26:1483\u20131489. https:\/\/doi.org\/10.1007\/s00467-011-1818-9","journal-title":"Pediatr Nephrol"},{"key":"9127_CR391","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01024-9","volume":"7","author":"XY Tang","year":"2022","unstructured":"Tang XY et al (2022) Human organoids in basic research and clinical applications. Signal Transduct Target Ther 7:168. https:\/\/doi.org\/10.1038\/s41392-022-01024-9","journal-title":"Signal Transduct Target Ther"},{"key":"9127_CR392","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.1038\/s41591-025-03788-3","volume":"31","author":"R Xiong","year":"2025","unstructured":"Xiong R et al (2025) AI-driven multi-omics modeling of myalgic encephalomyelitis\/chronic fatigue syndrome. Nat Med 31:2991\u20133001. https:\/\/doi.org\/10.1038\/s41591-025-03788-3","journal-title":"Nat Med"},{"key":"9127_CR393","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1056\/NEJMoa1917006","volume":"383","author":"K Kabashima","year":"2020","unstructured":"Kabashima K, Matsumura T, Komazaki H, Kawashima M (2020) Trial of nemolizumab and topical agents for atopic dermatitis with pruritus. N Engl J Med 383:141\u2013150. https:\/\/doi.org\/10.1056\/NEJMoa1917006","journal-title":"N Engl J Med"},{"key":"9127_CR394","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.876515","volume":"13","author":"T Hasegawa","year":"2022","unstructured":"Hasegawa T, Oka T, Demehri S (2022) Alarmin cytokines as central regulators of cutaneous immunity. Front Immunol 13:876515. https:\/\/doi.org\/10.3389\/fimmu.2022.876515","journal-title":"Front Immunol"},{"key":"9127_CR395","doi-asserted-by":"publisher","first-page":"720393","DOI":"10.3389\/fimmu.2021.720393","volume":"12","author":"Z Fang","year":"2021","unstructured":"Fang Z et al (2021) Gut Microbiota, Probiotics, and their interactions in prevention and treatment of atopic dermatitis: A review. Front Immunol 12:720393. https:\/\/doi.org\/10.3389\/fimmu.2021.720393","journal-title":"Front Immunol"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09127-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09127-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:48:55Z","timestamp":1770115735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09127-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":395,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9127"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09127-1","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5"}}